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ABSTRACT 
Accurate virus detection is important for diagnosis in a timely manner to facilitate 
rapid interventions and treatments. RNA viruses affect an extensive amount of the 
world’s population, particularly in tropical countries where emerging infectious agents 
often arise. Current diagnostic methods have three main problems: they are time 
consuming, typically not field-portable, and expensive. My research goal is to develop 
rapid, field-portable and cost sensitive diagnostic methods for RNA viruses. Herein, two 
different approaches to detect RNA viruses were proposed: Conjugated gold 
nanoparticles for detection of viral particles or virus-specific antibodies by monitoring 
changes in their optical properties, and Tentacle Probes coupled with qPCR for detection 
and differentiation of closely-related viral strains. The first approach was divided into 
two projects: the study and characterization of the gold nanoparticle-antibody system for 
detection of virus particles using dynamic light scattering (DLS) and UV-Vis 
spectrophotometry, and development of a detection method for antibodies using static 
light scattering (SLS) and antigen-conjugated gold nanoparticles. Bovine serum albumin 
(BSA) conjugated gold nanoparticles could successfully detect BSA-specific antibodies 
in vitro, and protein E from Dengue Virus serotype 2 conjugated gold nanoparticles could 
detect Dengue-specific antibodies, both in vitro and in serum samples. This method is 
more accurate than currently used detection methods such as dot blots. The second 
approach uses Tentacle Probes, which are modified molecular beacons, to detect with 
high specificity two different strains of Lymphocytic Choriomeningitis Virus (LCMV), 
Armstrong and Clone-13, which differ in only one nucleotide at the target sequence. We 
successfully designed and use Tentacle Probes for detection of both strains of LCMV, in 
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vitro and in serum from infected mice. Moreover, detection of as little as 10% of Clone-
13 strain was possible when diluted in 90% Armstrong strain. This approach enables the 
detection of different strains of virus even within a mixed quasispecies and may be 
important for improving intervention strategies for reducing disease. The detection 
methods provide rapid detection of viruses, including viral strains within mixed 
populations, and should enhance our ability in providing early responses to emerging 
infectious diseases due to RNA viruses including Zika or Dengue virus.  
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Chapter 1 
1. INTRODUCTION 
1.1 RNA Viruses 
Viruses that have genetic content single stranded RNA (ssRNA) or double 
stranded RNA (dsRNA) are called RNA viruses. Viruses with ssRNA are classified 
depending if they have a positive sense ssRNA, a negative sense ssRNA, or ambisense 
viruses, which encode proteins in both directions (Strauss & Strauss, 2007). 
Arenaviridae, Coronaviridae, Flaviviridae, Orthomyxoviridae, among other families, are 
part of the ssRNA virus families and include viruses that cause diseases like Yellow 
Fever, Dengue, Zika and Influenza (Guzman et al., 2010; Strauss & Strauss, 2007). 
Negative sense ssRNA virus’ genome has a replicase (RNA-dependent RNA 
polymerase), which is needed for their genome replication, and other proteins, like capsid 
proteins and non-structural proteins. Positive sense ssRNA viruses have a similar genome 
structure, but it uses more host proteins to replicate (Strauss & Strauss, 2007).  
RNA viruses have a higher rate of mutation than DNA viruses since they lack 
proofreading RNA polymerases. Despite this, there are some sequences that are 
conserved because they are needed for survival (i.e. RNA polymerase). The high 
mutation rate is mainly because of two reasons: high replication rate that lead to high 
number of viral particles, and fast viral generation time (Moya, Elena, Bracho, Miralles, 
& Barrio, 2000). This genetic variability can lead to the formation of quasispecies of a 
virus, which become important at the time of diagnosis or choosing the correct treatment 
(Domingo, Sheldon, & Perales, 2012; Lauring & Andino, 2010).  
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One of the most representative families of viruses among RNA viruses is the 
Flaviviridae family, which includes Yellow Fever Virus, Zika virus, Dengue virus, West 
Nile virus and Hepatitis C virus (Guzman et al., 2010; Hoen, Keller, Verma, Buckeridge, 
& Brownstein, 2012; T. F. Tsai & Halstead, 2001). Most of these viruses cause vector-
dependent viral diseases, are epidemic in many tropical countries and are emerging or re-
emerging viruses (Figure 1.1). Early virus detection is important to prevent viral 
outbreaks, especially in developing countries where a lack of control and surveillance 
mechanisms prevails (Guzman et al., 2010; Jelinek, 2009). Some of the viruses of the 
Flaviviridae family cause hemorrhagic fevers as well as viruses from the Arenaviridae, 
Filoviridae, Rhabdoviridae, and Bunyaviridae. Viral hemorrhagic fevers can be lethal 
even in the primary infection, like in the case of Ebola, or in the secondary infection, like 
in the case of Dengue (T. F. Tsai & Halstead, 2001).  
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Figure 1.1. Current Emerging and Re-Emerging Viruses in the World. 
Taken from (Marston et al., 2014). 
  
Lymphocytic choriomeningitis virus (LCMV) is part of the Arenaviridae family, 
is an emerging virus and is used in the following studies as a model virus for RNA 
viruses. The capsid and spike structure are similar to the ones present in other viruses 
such as Dengue virus, and its antigenic variance is evidenced in the different LCMV 
strains (Ahmed, Salmo, Butler, Chiller, & Oldstone, 1984; Zhou, Ramachandran, Mann, 
& Popkin, 2012). The LCMV wild type Armstrong strain differs with the Clone-13 strain 
in only three point mutations. One of these point mutations is translated in an amino acid 
difference in one of the receptor proteins (GP1), which causes that the infection to be 
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either acute (Armstrong) or chronic (Clone-13) (Ahmed et al., 1984). In the studies 
discussed in this dissertation, LCMV was used as a model virus for RNA viruses due to 
its well described biology and structure, as well as its immune response in mice.  
 
1.2 Detection Methods for Viruses 
Detection methods for viruses can be classified as directly, indirectly, immune-
detection and fluorescence-based technologies (Cella, Blackstock, Yates, Mulchandani, 
& Chen, 2013). Direct detection involves techniques were direct visualization is possible, 
like Electron Microscopy (EM), although this technique is primarily used to study viral 
biology and structure. Indirect detection are the most common techniques used that 
include amplification of nucleic acids and cell culture growth. The latter is still the “gold 
standard” technique for detection of viruses and discovery of new ones (Ahmed et al., 
1984). However, this technique is time consuming and lacks the specificity and 
sensibility of molecular techniques and need a priori knowledge of the identity of the 
virus (Ahmed et al., 1984; Cella et al., 2013; Korns Johnson & Homann, 2012). 
Immunology-based techniques are the most common indirect technique and rely mainly 
in the detection of antibodies against the virus, or detection of virus particles (Cella et al., 
2013; Driskell, Jones, Tompkins, & Tripp, 2011; Fukushi, Tani, Yoshikawa, Saijo, & 
Morikawa, 2012; Korns Johnson & Homann, 2012; Wong, Krupin, Sekaran, Mahamd 
Adikan, & Berini, 2014). The main problem with this type of technique in the possible 
cross-reaction detection between closely related viruses.  
Lastly, fluorescent-based techniques are molecular methods that monitor the 
fluorescence of probes that are complementary to the target or fluorescent dyes that bind 
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to dsDNA (Cella et al., 2013; Satterfield, Bartosiewicz, West, & Caplan, 2010; 
Satterfield, West, & Caplan, 2007). Although molecular methods such as PCR are highly 
sensitive, they require skilled lab technicians, careful storage of reagents, and cannot 
detect infective viruses (McCausland & Crotty, 2008). Thus, these methods are not the 
most appropriate to use in developing countries where fast and cost-effective detection is 
desired.  
 
1.3 Molecular Sensing: Fundamental Principles and Biomedical Applications 
Molecular sensing refers to any device that can detect and/or record a chemical or 
physical change in a property and has sensitivity and specificity at a molecular level 
(Zhang & Hoshino, 2014). Many of these modern molecular sensors are based in 
observations in nature and the one of the main applications is disease diagnosis. They 
have a variety of capture and recognition mechanisms including antibodies and other 
proteins, nucleotides, and polymers (Zhang & Hoshino, 2014). This recognition of a 
particular change is translated into a signal that can be electrical signal, optical or 
mechanical.  Optical signals are going to be main signal used during the following 
chapters.  
1.4 Nanophotonic Detection Devices 
Nanophotonic devices refer to the devices that study the change in optical 
properties at a nanoscale. Many times these devices use metallic colloids to amplify any 
change (chemical or physical) at small distances (i.e. surface of a gold nanoparticle) 
because of the plasmon resonance of the metallic nanoparticles (Compton & Osterloh, 
2007; Doak, Gupta, Manivannan, Ghosh, & Kahol, 2010; Haiss, Thanh, Aveyard, & 
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Fernig, 2007; Thanh & Rosenzweig, 2002; D.-H. Tsai et al., 2011).  Other applications 
include optical integrated circuits, photonic crystals, antennas for light and metamaterials 
(Koenderink, Alù, & Polman, 2015). Nowadays, this type of device is combined with 
other technologies and therefore expand the applications of both technologies. One 
example is the enhancement of single-molecule fluorescence with nanophotonics. Single-
molecule fluorescence is limited in some environments by the small concentrations of a 
single-molecule at the time of the measurements. Nanophotonic structures can amplify 
the excitation intensity play a critical role as an antenna and overcome the concentration 
barrier from single-molecule detection (Acuna, Grohmann, & Tinnefeld, 2014). 
Therefore, nanophotonic structures can be complementary to other current optical devices 
to improve any size dependent disadvantage and could have significant applications to 
the development of biosensors and therapeutical systems.  
1.5 Light Scattering Detection Devices 
As nanophotonic devices are being applied to multiple fields, it is important to 
highlight one of its applications: light scattering devices. Although other light scattering 
detection devices do not necessarily use nanophotonic structures (i.e. gold nanoparticles), 
the devices discussed in here are going to be associated to the use of gold nanoparticles.  
Light scattering devices coupled with gold nanoparticles are being applied 
broadly because of the scattering and amplifying properties of the gold nanoparticles, as 
discussed before. Static light scattering and dynamic light scattering are two of the most 
common techniques for detection of light scattering. These techniques give good results 
when samples have a high concentration of the solute in order to be detectable. Another 
technique is Raman scattering that is used with low concentrations, like single-molecule 
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experiments, gold nanoparticles enhance the signal (Fan, Zheng, & Singh, 2014). New 
applications of these light scattering and nanophotonics have led to new experimental 
developments such as optical trapping, optical tweezers and nanospasers, all of them 
enhanced by the plasmonic excitations with light (Fan et al., 2014). One example of an 
applied biosensor is the use of light scattering spectroscopy for early detection of cancer 
with minimal invasion, allowing real-time diagnosis (Perelman, 2006). Thus, light 
scattering devices are applied in biosensors widely and this opens new possibilities of 
applications of biosensors with the advantage of nanoparticles enhancing the signal. 
1.6 Kinetic Considerations: Detection, Stability and Aggregation Phenomena 
Aggregation in gold nanoparticles in solution is known to have an important role 
in the efficiency of electronic, magnetic or optical devices that use the gold nanoparticles 
(Mohammad, Abdelrahman, El-Deab, Okajima, & Ohsaka, 2008; Yang, Matsubara, 
Nogami, & Shi, 2007). The aggregation in solution is influenced by cationic and 
oligocationic species and causes a red-shifted displacement in the plasmon absorbance 
(Yang et al., 2007). Aggregation is also influenced by the pH of the medium. There has 
been evidence of linear aggregation when gold nanoparticles are in ethanol, but no 
evidence of aggregation when the nanoparticles are citrate-stabilized (Mohammad et al., 
2008). This means that gold nanoparticles will aggregate when the conjugate is not bound 
and/or the conjugation is not stable (Chen, Wang, Ge, & Zhao, 2009; Raoof et al., 2012).  
Kinetics influence the detection of optical change that is being monitored. Kim et 
al. (Kim, Lee, Joo, & Lee, 2008) described a model based on Brownian movements to 
predict aggregation in gold nanoparticles and it gave some insight into the optimization 
of colorimetric sensors using gold nanoparticles. In the case of UV-Vis 
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spectrophotometry, aggregation can be observed in the red-shifted plasmon peak and in 
the region of 640-680 nm (Thanh & Rosenzweig, 2002; Thobhani et al., 2010; Yang et 
al., 2007).   
 
The following studies intend to give an insight of new detection methods and a 
better understanding of the viral detection methods by approaching current problems with 
diagnostic methods: cost-effectiveness, fast diagnosis, field-portable and specificity of 
the method. The two approaches discussed cover different areas of application of the 
diagnostic methods, and the use of each approach depend on the need of the 
researcher/clinician. The first approach, a nano-device coupled with static light scattering 
successfully detect antibodies in a serum sample. The second approach, a molecular 
fluorescent-based method coupled with qPCR, is highly specific even in the presence of 
multiple strains in a sample. Herein, factors affecting both approaches are studied and 
discussed to optimize each method and obtain better detection results.  
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Chapter 2 
2. OPTIMAL CONDITIONS AND PROTOCOLS FOR PREPARATION OF GOLD 
NANOPARTICLES 
2.1 Introduction 
Gold nanoparticles (AuNPs) are highly sensitive to chemistry surface changes and 
have already been employed as sensors for biomedical applications and for cancer 
therapy (Daniel & Astruc, 2004; Raoof et al., 2012; Thobhani et al., 2010). Changes at 
the surface of nanoparticles can be monitored using any of a number of their optical 
properties including surface plasmon resonance, optical absorption or scattering, 
fluorescence, among others (Compton & Osterloh, 2007; Daniel & Astruc, 2004; Doak, 
Gupta, Manivannan, Ghosh, & Kahol, 2010; van Dijk, 2007). AuNPs have previously 
been used for virus detection of H5N1 (Pham, Hoang, Phan, Conrad, & Chu, 2012), 
Influenza (Driskell, Jones, Tompkins, & Tripp, 2011) and Dengue using RNA isolated 
from mosquitoes (Carter, Balaraman, Kucharski, Fraser, & Fraser Jr, 2013). These are 
examples in which the optical properties of AuNPs have been coupled with different 
analytical techniques.  
While over the past several decades, approaches for synthesizing, preparing, and 
detecting gold nanoparticles for homogeneous assays have been described, important 
challenges remain when translating their use from successful applications of gold 
nanoparticles in heterogeneous assays to reliable and sensitive homogeneous assays (Du, 
Li, & Cheng, 2008; Linares, Kubota, Michaelis, & Thalhammer, 2012). The motivation 
for the development of homogeneous assays is to increase assay speed and improve 
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sensitivity of detection by utilizing instrumentation suitable for liquid phase 
measurement. 
There are three main steps for the preparation and detection of antibodies with 
conjugated gold nanoparticles: conjugation of the nanoparticles, centrifugation and 
incubation with sample. Chemically, the conjugation step to the protein usually takes 
place either through covalent S-S bonds (directional) or non-covalent bonding (Kumar, 
Aaron, & Sokolov, 2008; Raj & Sreenivasan, 2010; Tsai et al., 2011). The amount of 
protein needed to cover the surface of the gold nanoparticles is often determined 
empirically by titration of the protein. However, the titration is not always efficient to 
cover the majority of the gold nanoparticles and can result in increased non-specific 
binding of analyte and less efficiency (Brewer, Glomm, Johnson, Knag, & Franzen, 
2005). The centrifugation step is critical to remove free protein in solution to avoid 
unspecific binding of free protein to conjugate with their target (La Belle, Faichild, 
Demirok, & Verma, 2013). Speed and times in this step vary depending on the size of the 
gold nanoparticles, and can be performed one or more times, but the resuspension step of 
the nanoparticles is not well described in literature. Lastly, incubation of the gold 
nanoparticles with the sample has been described at varying temperatures, but has not 
been accurately assessed for variance. 
For researchers and method developers inexperienced in gold nanoparticle assays, 
there are a number of commercial web sites that describe specific steps and numerous 
research articles reporting findings for homogeneous immunoassays.  However, the lack 
of detailed descriptions of gold nanoparticle preparation steps can lead to confusion 
regarding optimal preparation. Subsequently, low sensitivity or spurious results can 
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occur.  Even for researchers with experience using gold nanoparticle in heterogeneous 
assays, translating the format to homogeneous assays can pose new challenges since steps 
to bind antibodies and proteins to gold surfaces requires careful attention to preparative 
steps in order to maintain sensitivity due to the presence of free antibody and protein. 
Hence, a detailed procedure is proposed for the preparation of gold nanoparticles 
that includes the three main steps: conjugation of the protein, centrifugation and 
incubation with the target. As a proof of concept, the procedure was tested with the 
conjugation of Bovine Serum Albumin (BSA) to 60 nm gold nanoparticles and posterior 
recognition of the anti-BSA antibody. The procedure was optimized to obtain the best 
results for the detection of the target using static light scattering and UV-vis 
spectrophotometry.  
 
2.2 Proposed Procedure for the Conjugation of Gold Nanoparticles 
Conjugation: 
An aliquot of 1 ml containing 2.6 x 1010 particles/ml of 60 nm gold colloids is 
combined with 50 or 100 microliters of freshly prepared pH = 5 acetate buffer 
(appropriate for BSA conjugation) prior to the addition of 100 microliters of from 0.5 
mg/ml BSA.   A frozen cold pack was placed on the tube and the mixture was gently 
rocked using an orbital table for 30 minutes as a practical incubation time for BSA 
binding. 
Centrifugation: 
Three centrifugation steps are conducted in order to reduce the concentration of 
BSA not bound to gold nanoparticles.  The centrifugation conditions used were adapted 
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from Cytodiagnostics Inc. (www.cytodiagnostics.com) recommended conditions. To 
minimize aggregation of gold nanoparticles and ensure re-suspension after centrifugation 
all centrifugation steps should be at 4 ˚C. All centrifugation steps should be for 30 
minutes at 1,125×g. After each step, remove as much of the supernatant as possible 
without touching the pellet. Resuspend the pellet with 1 ml of pH = 5 acetate buffer after 
the first and second centrifugation steps, and resuspend with 1 ml of phosphate buffer 
saline (PBS) pH = 7.0 after the final centrifugation step.  
Incubation: 
Incubation of the gold nanoparticle preparation with 10 or 100 µl of sample for 30 
min could be at room temperature or at 37 ˚C with constant rocking.  
 
2.3 Results  
2.3.1 Conjugation of Gold Nanoparticles 
The pH of the buffer used for conjugation of the protein to the gold nanoparticles 
is going to influence the net charge of the protein and the surface interactions with the 
gold nanoparticle. Usually this pH is above the isoelectric point (pI) of the protein for 
binding, and for BSA the most appropriate buffer was acetate buffer (pH = 5). To 
determine the amount of buffer necessary to add to the gold nanoparticles different 
amounts of acetate buffer were tested. Fifty microliters and 100 µl of acetate buffer 
induced aggregation of the gold nanoparticles evidenced by a color change in the solution 
from pink to purple or gray and the tailing seen in the 600-800 nm region in the visible 
light extinction spectrum compared to the spectrum of the gold nanoparticles without the 
buffer. Ten microliters of acetate buffer did not induced aggregation of the gold 
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nanoparticles, a result confirmed by visible spectroscopy (results not shown). 
The amount of protein added to the solution for conjugation to the gold 
nanoparticles is also important because a sufficient amount of protein on the surface of 
the gold nanoparticles will protect the particles from aggregation in the presence of 
sodium chloride. Stoichiometric calculations based on surface coverage were performed 
to ensure that at least an average of 10 molecules of BSA were present on the surface of 
the gold nanoparticles. A concentration of 0.5 mg/ml of BSA was enough to have this 
coverage, which was confirmed visually after the centrifugation steps and final re-
suspension with PBS by lack of color change.  
In connection with these results, Tsai et al. (2011) referred that to get 90% 
coverage of the gold nanoparticle of the same size, at least a 2 mg/ml BSA solution was 
needed. For this reason, a 7 mg/ml solution of BSA in DI H2O was used for the 
conjugation step to ensure the maximal saturating coverage of the gold nanoparticles. The 
procedure was repeated having as a result a lack in color change of the gold nanoparticles 
in the presence of PBS, and the visible spectrum showed no signs of aggregation 
compared to the spectrum of the gold nanoparticle solution before conjugation (not 
shown). 
2.3.2 Centrifugation  
After 30 min of incubation with the protein to conjugate, usually there is excess of 
free protein in solution, which would interfere with the assay because the interaction of 
free protein with antibodies will not be detected. This problem is addressed using 
centrifugation to remove the supernatant containing the remaining protein in solution. 
This step can be done one or many times. For this purpose, three steps of centrifugation 
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were proposed for gold nanoparticles of 60 nm of diameter, conjugated with BSA. 
Supernatant was collected after each centrifugation step and the UV-Vis spectrum of the 
supernatant was measured to monitor the amount of BSA present. Figure 2.1 shows that 
after the second and third step of centrifugation, the amount of BSA in the supernatant 
collected was minimum.  
 
Figure 2.1. Three Centrifugation Steps are Enough to Eliminate Free Protein after 
Conjugation.  
UV-Vis spectra of different known concentrations of BSA (0.0005-0.5 mg/ml) compared 
to the supernatants collected after each centrifugation step.  
 
After the first centrifugation step of gold nanoparticles incubated with 0.5 mg/ml, 
the supernatant was removed carefully and the red pellet was re-suspended in 1 ml of 
acetate buffer. A second round of centrifugation at the same conditions was performed 
and a black pellet obtained could not be re-suspended. To solve this problem, 0.25 % of 
Tween 20 surfactant was added to the buffer used for re-suspension to help the gold 
nanoparticles disperse.  
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To determine the optimal time of each one of the three steps of centrifugation, a 
second round of centrifugation during 30 minutes using the surfactant and acetate buffer 
for each re-suspension was carried out. As a result, a black pellet was obtained after two 
centrifugations and it couldn’t be re-suspended. Therefore, the time of centrifugation of 
the second step was decreased from 30 min to 15 min and the third centrifugation time 
was also reduced from 15 min to 10 min to favor re-suspension of the gold nanoparticles. 
This reduction in centrifugation time enabled the re-suspension of the gold nanoparticles 
after three steps of centrifugation. The buffer used to re-suspend after the third 
centrifugation step was PBS. These conditions were also tested and confirmed as optimal 
with gold nanoparticles conjugated with a solution of 7 mg/ml of BSA.  
2.3.3 Incubation  
To test if increasing the temperature during incubation with the antibody would 
result in an enhanced detection of binding, incubation at 40 ˚C during 30 min with 
different amounts of antibody was tried. Figure 2.2 shows static light scattering 
measurements of each sample with increasing concentrations of antibody. The results are 
similar to the results obtained at room temperature. The different intensity counts likely 
indicate fewer aggregates in solution because they precipitated over time. Therefore, 
changes in incubation temperature do not affect significantly the trend of detection when 
more antibody is added to the conjugated AuNPs.   
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Figure 2.2. Incubation of Antibody with Conjugated Nanoparticles at Different 
Temperatures.  
Light scattering at 532 nm measured at RT after 0 min or after 30 min at 37 ˚C of 
addition of 0-10 µg/ml of antibody anti-BSA (right). 
 
 
2.4 Discussion 
2.4.1 Binding Protein 
The conventional approach to preparing gold nanoparticles for assays is to 
perform a titration by continually adding higher concentrations or amounts of protein so 
that when the mixture is “challenged” by the addition of a high concentration of sodium 
chloride solution (about 10% or 5 M), the amount of protein adsorbed on the surface of 
the gold nanoparticles can avoid aggregation and subsequent precipitation from solution.  
This titration test is reasonably simple to conduct and can be a cost-effective way of 
preparing particles with expensive proteins or monoclonal antibodies.  It also would 
appear reasonable that adding another protein or blocking agent to cover the gold 
nanoparticle surface that may still be exposed leading to unintended non-specific binding, 
is a complementary step that mirrors traditional ELISA methods.  However, as discussed 
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by several researchers (Brewer et al., 2005; Engleienne, 1998), this may lead to quite low 
surface coverage by the protein – as low as 10%.  Assay sensitivity and analysis speed 
may be lower as a result since both are driven by the overall antibody accessible protein 
concentration.  Moreover, for the detection of antibodies in response to a disease state, 
higher surface coverage can improve the probability of bridging multiple particles, given 
that the target is a polyclonal population of antibodies with multiple binding sites.  
Therefore, it is recommended that, when possible, the concentration of the protein used 
for conjugation would be in excess to ensure maximum coverage. However, the practical 
tradeoff between cost and sensitivity/speed is also complicated by the possibility of BSA, 
when used as a blocking agent, to get unspecific binding.  It may also be useful to 
determine if BSA, or any other blocking agent used for other protein immunoassays, 
yields unwanted false positives in the case there is too little of the target protein on the 
surface and components or buffers present in the sample could promote protein-protein 
aggregation, specific and unspecific. 
2.4.2 Centrifugation 
Introducing a multi-step centrifugation to remove unbound protein appears to be 
worthwhile for homogeneous assays based on experience and reports by several 
researchers (Du et al., 2008; Gilger et al., 2001; Huang, 2006; La Belle et al., 2013; Raj 
& Sreenivasan, 2010).  In some published gold nanoparticle preparations, there are 
membrane or dialysis alternatives to centrifugation (Aslan, Holley, Davies, Lakowicz, & 
Geddes, 2005) but most proteins are too large for proper removal using this method.  
Moreover, when the technique for supernatant removal is well honed, centrifugation can 
be done relatively easily and quickly.  
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In the experiments with 60 nm gold nanoparticles, the addition of a small amount 
of Tween 20 and centrifugation at 4 ˚C was determined to be very important for avoiding 
irreversible aggregation leading to the loss of gold nanoparticles. Also, time and 
centrifugation force recommendations published in articles and on commercial web sites 
should only be regarded as initial guidelines.  Shorter times and lower centrifugal forces 
may provide better and more consistent results, as it was observed in the experiments 
described.  This may be due to the variability of protein coverage and aggregation 
behavior for different protein binding preparations. Whatever combination of conditions 
used, it should be noted that the most important goal of this step is to remove as much 
unbound protein as possible without significant loss of gold nanoparticles in the 
suspension or due to pellets that cannot be fully re-suspended.  Multiple and shorter 
centrifugation steps may be better than a single longer centrifugation, especially for large 
gold nanoparticles. It is important to mention that the pellet should not be allowed to sit 
for more than 2-3 min before re-suspension because of the tendency of the gold 
nanoparticles to remain aggregated, even after different attempts of resuspension.  
 
2.5 Conclusions and Recommendations 
There are a number of specific steps and some overall observations that are 
important to note based on the data and observations obtained during this study. The 
centrifugation steps are essential for minimizing the amount of non-conjugated protein 
left in the suspension, but care must be exercised in order to avoid conjugate particle 
instability. Specifically, one of the key factors is the time between each centrifugation 
step, as discussed before.   
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Secondly, the amount of protein added depends on several factors, including 
relative cost and quantity of protein available for assay use. A higher concentration of 
protein is preferred because it leads to higher gold nanoparticle surface coverage as 
compared to conjugation with the minimum amount of protein used in titration, which 
would suggest better capacity for immunoassay detection because of the probability of 
binding to the target. When sufficient protein is not available and hence the concentration 
of protein used for binding is low, it is recommended that a suitable blocking agent can 
effectively help maintain conjugated gold nanoparticle stability. The choice of blocking 
agent can also depend upon other aspects of the immunoassay, and there are other 
alternatives in the literature.  
Another aspect that needs attention is incubation with the target protein, either 
antibody or antigen depending on the system, can be performed at 37-40 ˚C to increase 
the interactions and obtain better assay results. Before incubation with the target protein, 
it is preferable to let the conjugated gold nanoparticles sit overnight to avoid possible 
aggregates interfere with the light scattering measurement in the presence of the target.  
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Chapter 3 
3. VIRUS PARTICLE DETECTION USING NANO-SENSORS 
3.1 Introduction 
Effective and accurate diagnostic methods are needed in vector-dependent viral 
diseases, such as Yellow Fever, Dengue or Zika, which are epidemic in many tropical 
countries and recently extending their global reach to the US (Guzman et al., 2010; Hoen, 
Keller, Verma, Buckeridge, & Brownstein, 2012; Jelinek, 2009). Early virus detection is 
important to prevent viral outbreaks, especially in developing countries where there is a 
lack of control and surveillance mechanisms (Guzman et al., 2010; Jelinek, 2009). Virus 
detection methods employed currently, include molecular methods (McCausland & 
Crotty, 2008), isolation and quantification of the virus in cell culture (Ahmed, Salmo, 
Butler, Chiller, & Oldstone, 1984), and detection in serum of virus-specific antibodies 
(Korns Johnson & Homann, 2012). Although molecular methods such as PCR are highly 
sensitive, they require skilled lab technicians, careful storage of reagents, and cannot 
detect infective viruses (McCausland & Crotty, 2008). Techniques based on isolation of 
the virus in cell culture, such as the classical plaque assay, are accurate but require at 
least one week for diagnosis, are not sensitive, and need a priori knowledge of the 
identity of the virus (Ahmed et al., 1984; Korns Johnson & Homann, 2012). Thus, these 
methods are not appropriate for developing countries where fast detection is desired.  
Additionally, poor field conditions and limited training restrict application of many virus 
detection methods. 
Gold nanoparticles (AuNPs) are often used as molecular sensors. The sensing 
capability is associated to surface changes, which can be monitored by changes in the 
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optical properties including surface plasmon resonance, optical absorption or scattering 
and fluorescence (Compton & Osterloh, 2007; Daniel & Astruc, 2004; Doak, Gupta, 
Manivannan, Ghosh, & Kahol, 2010; van Dijk, 2007). AuNPs have previously been used 
for virus detection of H5N1 (Pham, Hoang, Phan, Conrad, & Chu, 2012), Influenza 
(Driskell, Jones, Tompkins, & Tripp, 2011) and Dengue using RNA isolated from 
mosquitoes (Carter, Balaraman, Kucharski, Fraser, & Fraser Jr, 2013).  
In this study, AuNPs coupled with an antibody are used for the detection of virus 
particles (whole virus or the specific surface protein). For this purpose, a virus model for 
RNA viruses, Lymphocytic Choriomeningitis Virus (LCMV), was used. Detection of a 
surface protein in LCMV (GP1) is using the change in optical properties of gold 
nanoparticles. The changes in the surface plasmon resonance intensity and maximum 
frequency shift of the AuNPs were monitored observing the absorbance spectrum. 
Dynamic light scattering (DLS) was also used to monitor size changes associated to the 
detection of virus samples obtained in vitro. 
 
3.2 Materials and Methods 
3.2.1 Mice and Virus  
Lymphocytic Choriomeningitis Virus strain Clone13 (LCMVCL13) was harvested 
on BHK cells in Gibco® Minimum Essential Media (MEM) with phenol red (Thermo 
Fisher Scientific, Pittsburgh, PA https://www.fishersci.com/us/en/home.html) or 
Phosphate Buffer Saline (PBS) with 5 % Fetal Bovine Serum (FBS) and tittered on Vero 
cells by plaque assay (Ahmed et al., 1984). 
3.2.2 Antibody and Reagents 
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Anti-LCMV antibody IgG isotype 1 (Cat. N˚: BM5090; Acris Antibodies Inc., 
Rockville, MD, https://us.acris-antibodies.com)  was dialyzed in borate buffer (pH = 8.5) 
and stored at 4 ˚C. The final concentration was 0.2 mg/mL, measured using 
Nanodrop1000 (mass e= 14.00). Gold nanoparticle (AuNPs) Sols (Ted Pella Inc, 
Redding, CA, http://www.tedpella.com) of 10 nm and 40 nm diameter (citrate stabilized), 
and phosphate buffered saline (PBS; Thermo Fisher Scientific, Pittsburgh, PA 
https://www.fishersci.com/us/en/home.html) was filter sterilized, both stored at 4 ˚C. 
3.2.3 Antibody Conjugation to AuNPs 
Gold nanoparticles (AuNPs) of 10 nm and 40 nm were obtained from Ted Pella, 
Inc. To determine the minimum amount of antibody needed to conjugate to the AuNPs, 
20 µL of different concentrations of antibody from 0.01-0.2 mg/mL were added to 1 mL 
of AuNPs and 100 µL of Borate buffer (pH=8.5). These solutions were challenged with 
NaCl (10%) to observe aggregation of the AuNPs (color change from pink to purple). 
The solution that did not aggregate had the minimum amount of antibody, or more, to 
protect the AuNPs from aggregation. These observations were also monitored measuring 
the UV-Vis spectra of the solutions looking for the formation of the characteristic 
plasmon peak at 525 nm and a concave curvature around 640-680 nm.  
3.2.4 UV-Vis Spectrophotometry and Dynamic Light Scattering 
UV-Vis spectra of samples with only AuNPs (10 nm and 40 nm), antibody 
conjugated AuNPs and antibody conjugated AuNPs with different concentrations of virus 
were measured a wavelength range of 200-900 nm with an Ocean Optics USB4000 UV-
Vis Spectrometer (Ocean Optics, Inc., Dunedin, FL, http://oceanoptics.com). Dynamic 
light scattering measurements of the same samples were taken using a SpectroSize 300 
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(Molecular Dimensions, Altamonte Springs, FL, http://www.moleculardimensions.com). 
The laser wavelength is at 690nm at 170˚. Twenty measurements were taken over 30 sec 
in each measurement and each sample was measured 2-3 times. 
 
3.3 Results 
3.3.1 Titration of the Amount of Antibody Bound to the Gold Nanoparticles 
The technique used in this study is based on the modifications of the surface 
plasmon of gold nanoparticles (Compton & Osterloh, 2007). The antibody is adsorbed on 
the AuNP by non-covalent forces and when it encounters a viral particle, the gold 
nanoparticle changes its optical properties. Using an optimal amount of antibody is 
crucial (Pham et al., 2012). therefore, different amounts of anti-LCMV antibody (0‑4 µg) 
were adsorbed on the surface of 1 mL of ~10 nm AuNP Sols (~5×1012 AuNPs) and 1 mL 
of ~40 nm AuNP Sols (~9×1010 AuNPs), separately. Excess of antibody leaves free 
antibody in solution that can bind LCMV, but this interaction will not be detected in the 
absorption spectrum because it does not lead to detectable surface changes on AuNPs. 
Nonetheless, if there is not enough antibody adsorbed to the AuNPs, the surface 
of the nanoparticles adsorbs salt ions with the addition of NaCl making the surface 
neutral, which changes the plasmon signal and the gold nanoparticles aggregate observed 
by a color change (Thobhani et al., 2010b). To avoid interference with this salt addition, 
dialysis of the anti-LCMV antibody was necessary. To determine the optimal amount of 
antibody, solutions of AuNPs with different concentrations of antibody were treated with 
1 M NaCl and the UV-vis absorbance spectra were obtained. Figure 3.1 shows 
absorbance spectra from AuNPs treated at a range of anti-LCMV antibody 
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concentrations. Upon treatment of AuNPs with anti-LCMV antibody, the absorption 
increased due to changes in the surface plasmon. By increasing the amount of 
anti-LCMV antibody, less AuNP surface is exposed causing a concomitant change in the 
absorbance spectrum. The characteristic plasmon resonance peak (520‑540 nm) (Daniel 
& Astruc, 2004; Doak et al., 2010) becomes more prominent when more antibody is 
added and the formation of a concave curve around 580‑690 nm is observed. Figure 3.1A 
and 3.1B show the visible spectra of the titration for 10 nm and 40 nm particles, 
respectively. For 10 nm AuNPs, initial changes in the plasmon reasonance peak were 
observed when 0.6 µg (0.48 µg/µL) were added, but concavity in the 580-690 nm region 
was absent (pink). The minimum amount of antibody required to observe both changes 
was 0.8 µg (0.64 µg/µL; purple). Additional antibody aliquots did not improve the signal. 
The spectra obtained following the addition of 1 µg (blue) and 4 µg (not shown) had the 
same features as the spectrum obtained with the sample using 0.8 µg. Performing a 
similar analysis with the 40 nm AuNPs (Figure 3.1B), the minimum amount of antibody 
required to observe both changes was 1.6 µg (1.28 µg/µL; blue). Experiments were 
repeated in triplicate, obtaining the same results (data not shown). The data was 
supported by the color change, from pink to purple, of the solutions after the treatment 
with NaCl (data not shown). 
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Figure 3.1. Titration Using NaCl of Gold Nanoparticles with a Range of Concentrations 
of Anti-LCMV Antibody.  
A) For 10 nm gold nanoparticles. B) For 40 nm gold nanoparticles.   
 
After determining the minimum amount of antibody to add to 1 ml of AuNPs for 
each size, the adsorption of the antibody was confirmed through UV-Vis spectroscopy 
and Dynamic Light Scattering (DLS). When comparing the spectra of unconjugated 
AuNPs and antibody conjugated AuNPs, the plasmon peak should have a shift to longer 
wavelengths (Pham et al., 2012; Thobhani et al., 2010a). Figure 3.2 shows a shift in the 
plasmon peak to the infrared wavelength when the AuNPs were conjugated with the 
antibody for both sizes of AuNPs, 10nm (Figure 3.2A) and 40 nm (Figure 3.2B).  
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Figure 3.2. Visible Spectra of Antibody Conjugated Gold Nanoparticles. 
Vis spectra of gold nanoparticles with and without antibody adsorbed in the surface of the 
gold nanoparticles for A) 10 nm gold nanoparticles and B) 40 nm gold nanoparticles. 
 
DLS measurements with 40 nm unconjugated AuNPs showed an increase of the 
hydrodynamic radius after the conjugation of the antibody with the gold nanoparticles. 
Top panel of Figure 3.3 shows average radius of ~18.9 ± 0.52 nm for the gold 
nanoparticles, which is as expected (~20 nm). Bottom panel of Figure 3.3 shows the 
intensity counts of 40 nm AuNPs after the conjugation with the antibody.  The average 
radius for conjugated AuNPs is ~21.9 ± 0.21 nm, with a high intensity count (sharp 
peak). The increase in diameter corresponds to the adsorption of the antibody. 
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Figure 3.3. Dynamic Light Scattering of Antibody Conjugated Gold Nanoparticles. 
Evidence of successful conjugation or adsorption of the antibody to 40 nm gold 
nanoparticles observed by an increase in hydrodynamic radius of the particle. Intensity 
counts for gold nanoparticles without antibody (top) and with antibody conjugated 
(bottom) were measured.  
 
3.3.2 Factors that Affect the Assay Measurements 
Once the antibody was conjugated to the AuNPs, a standardized method would be 
used to monitor the changes in the optical properties of the AuNPs to determine the 
presence of a virus particle. To understand how the assay could be affected, three factors 
were tested: the medium in which the virus is harvested, pH of the medium or sample, 
and the blocking agent used in the conjugation of the antibody. The components of the 
medium in which the virus is harvested are important factors to take into account when 
analyzing the changes in the conjugated gold nanoparticles spectrum. These components 
can include pH indicator, fetal bovine serum (FBS) or amino acids (Thermo Fisher 
Scientific, 2016). Some amino acids and pH indicators, like phenol red, can absorb in the 
UV region (Sigma-Aldrich, 2016; Thermo Fisher Scientific, 2016). Figure 3.4 shows the 
effect of the color of the medium (MEM) due to the pH indicator red phenol. In each of 
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the samples that contained MEM with red phenol (yellow, red and black), there is a shift 
of the plasmon peak to the infrared and a shoulder around 520 nm. This effect 
corresponds to the absorption peak of the red phenol in its basic form (l=557 nm) 
(Sigma-Aldrich, 2016). After observing the interference of the red phenol in the UV-Vis 
spectra of the conjugated AuNPs, the medium used for harvesting virus did not have a pH 
indicator, and therefore exhibited no color.  
 
Figure 3.4. Effect of the Medium in which the Virus is Harvested.  
Visible spectra of AuNPs with and without conjugated antibody in the presence of virus 
supernatant or mock (blank). The spectrum of antibody conjugated AuNPs was used as 
control. 
 
Another factor that could influence the UV-Vis measurements is the pH of the 
sample because it can alter the chemistry of the gold nanoparticles surface or destabilize 
the protein conjugated to the gold nanoparticle (Brewer, Glomm, Johnson, Knag, & 
Franzen, 2005; Du, Li, & Cheng, 2008; Thobhani et al., 2010a; Tsai et al., 2011). To test 
the effect of pH, the conjugated gold nanoparticles were mixed in a 1:1 proportion with 
media (without phenol red) at different pH values. Figure 3.5 shows the UV-Vis spectra 
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of the conjugated gold nanoparticles at pH 6-8. It is observed that pH affects the plasmon 
peak intensity of the conjugated gold nanoparticles.  
 
Figure 3.5. Effect of pH on the Light Extinction of Conjugated AuNPs. 
Visible spectra of antibody conjugated AuNPs in the presence of medium (MEM without 
pH indicator) at different pHs. 
 
To study this effect in more depth, the UV-Vis spectra of conjugated gold 
nanoparticles with media at different pH values were measured for 45 - 50 minutes at 5 
min intervals. Figure 3.6 shows the initial (t=0 min) and final (t=45 min or t=50 min) 
spectra of conjugated gold nanoparticles at different pH values. At pH=6, 7.5 and 8, the 
light extinction of the conjugated AuNPs decreases, representing instability of the ligand 
(antibody) as a conjugate. At pH=6.5 and 7 the light extinction is unchanged over that 
period of time, suggesting stability of the interactions of the protein with the AuNPs over 
time. 
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Figure 3.6. Effect Over Time of pH on the Light Extinction of Conjugated AuNPs. 
Light extinction of antibody conjugated AuNPs in the presence of medium (MEM) 
without pH indicator at different pH values for 45 min at 5 min intervals. A) At the 
plasmon peak (522 nm), and B) at the aggregation region of 640-680 nm (658 nm). 
 
Lastly, the use of a blocking agent during conjugation and its concentration, can 
have an effect on the interaction of the antibody and the virus. The blocking agent can 
block not only the empty spaces on the surface of the AuNPs, but also the sites of specific 
interaction between the virus particles and the antibody. For this reason, different 
concentrations of fetal bovine serum (FBS) and BSA were used as blocking agent during 
the conjugation step. Figure 3.7 shows that the minimum concentration of FBS to have 
the same effect as the one observed with BSA is 1%. The effect of the blocking agent is 
minor after a certain concentration, as expected, because it means that the empty spaces 
on the surfaces have adsorbed the blocking protein, and therefore increased the stability 
of the conjugated gold nanoparticles.  
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Figure 3.7. Effect of Blocking Agent on Light Extinction of Conjugated AuNPs. 
Visible spectra of antibody conjugated AuNPs using different concentrations of FBS or 
BSA as blocking agents during the conjugation with the antibody. 
 
3.3.3 Virus detection 
After determining what were the conditions at which pH, blocking agent and 
medium do not affect the UV-Vis measurement, these optimized conditions were used to 
detect optical changes specific to the interaction between the antibody on the surface of 
the gold nanoparticle and the virus particle.  For this purpose, conjugated gold 
nanoparticles were exposed to different concentrations of virus and PBS was used as a 
negative control. Figure 3.8A shows the UV-Vis spectra of 10 nm conjugated gold 
nanoparticles in the presence of different virus concentrations. Although the plasmon 
peak intensity changes with different viral concentrations, there is no clear trend of this 
change as the virus concentration increases. Figure 3.8B shows the light extinction 
change at 522 nm, which is the wavelength where the plasmon peak is observed for this 
nanoparticle size. It was observed that fluctuations exist and the readings do not indicate 
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a steady trend when the amount of virus particles is increased. This is observed in the 
three replicas of the experiment (sample 1, 2 and 3).  
 
 
Figure 3.8. Solution of 10 nm Conjugated AuNPs in the Presence of Virus Dilutions. 
A) UV-Vis spectra of antibody conjugated AuNPs with dilutions of a virus sample 
(2×100-2×106 P.F.U.). B) Light extinction at 522 nm (plasmon peak) of antibody 
conjugated AuNPs in the presence of different virus dilutions (2×100-2×106 P.F.U.) in 
triplicate.  
 
To determine if the size of the gold nanoparticle had any effect on the results,  the 
same experiment performed with 10 nm conjugated gold nanoparticles was repeated with 
40 nm conjugated gold nanoparticles. Figure 3.9A shows the UV-Vis spectra of 40 nm 
conjugated AuNPs in the presence of increasing concentrations of virus. The results are 
similar to the results observed with 10 nm conjugated gold nanoparticles. Looking 
closely at the changes in the light extinction on the plasmon peak (Figure 3.9B), the 
results are not reproducible between samples, except when the virus is at its highest 
concentration (2×106 P.F.U.) which for two samples generates the highest light extinction 
among the rest of the samples.  
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Figure 3.9. Solution of 40 nm Conjugated AuNPs in the Presence of Virus Dilutions. 
A) UV-Vis spectra of antibody conjugated AuNPs with dilutions of a virus sample 
(2×100-2×106 P.F.U.). B) Light extinction at the plasmon peak (528 nm) of antibody 
conjugated AuNPs in the presence of different virus dilutions (2×100-2×106 P.F.U.) in 
triplicate.  
 
To confirm the recognition of the virus through an antibody conjugated AuNP, 
DLS measurements at the addition of virus to antibody conjugated AuNPs were 
performed. To confirm the size of the virus, a separate sample with only virus was 
measured (Figure 3.10, middle). The hydrodynamic radius of the virus sample suggested 
a non-homogeneous size in the virus sample because of the presence of a broad peak 
around 65.38 ± 3.45 nm. Nevertheless, an average diameter of 120 nm of the virus is 
within the expected size range for LCMV (Neuman et al., 2005). When the virus is added 
to antibody conjugated AuNPs (Figure 3.10, bottom), there is no increase in the radius 
(66.06 ± 3.59 nm) and there is no perceived peak that would represent the conjugated 
AuNPs by themselves.  
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Figure 3.10. Hydrodynamic Radius of Conjugated Gold Nanoparticles and Virus. 
Dynamic light scattering measurements of 40 nm antibody conjugated AuNPs (top), virus 
(2×105 P.F.U./ml; middle) and the conjugated gold nanoparticles in the presence of the 
virus (bottom).  
 
3.4 Discussion 
AuNPs are broadly used in different fields, for example, as biosensors (Aslan, 
Lakowicz, & Geddes, 2004; Bogdan et al., 2012; Driskell et al., 2011; Pham et al., 2012). 
AuNPs are used in this study as biosensors to determine the amount of virus in different 
samples. Determination of the optimal amount of antibody to conjugate with AuNPs is an 
important step (Pham et al., 2012). The optimal amount of anti-LCMV antibody 
determined for 1 mL of AuNPs Sols was 0.8 µg and 1.6 µg for 10 and 40 nm AuNPs, 
respectively (Figure 3.1). These values were supported by the color change from pink to 
gray or purple when 1 M NaCl was added to these solutions. The color change is due to 
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aggregation of AuNPs resulting from replacement with surface-bound citrate ions by 
chloride ions (Thobhani et al., 2010b). Although the spectra obtained with an excess of 
antibody were similar to the spectrum obtained using an optimal amount of antibody, it is 
important to not exceed the amount of antibody that can bind the AuNPs because free 
antibody in solution would interfere with the sensitivity of the method and reduce the 
cost-benefit advantage of our technique.  The absorbance spectrum with the minimum 
amount of antibody had two important features: the formation of a characteristic plasmon 
peak at 510-530 nm (Daniel & Astruc, 2004) and a rapid decrease in absorbance between 
640 and 690 nm, leading to a formation of a concave curve between 580-690 nm. The 
latter is the feature that was analyzed throughout this study. The plasmon peak was not 
analyzed because there are many environmental variables that can change the intensity of 
the peak or cause a shift in wavelength (van Dijk, 2007). Based on this result, the 
stoichiometry of antibodies conjugated to each 10 nm AuNP was calculated giving ~0.57 
antibodies per 10 nm AuNP. This means that not all of the AuNPs are covered with the 
protein (anti-GP1 antibody), which can lead to unspecific interactions with the virus 
particles when exposed to the virus. For this reason, other types of conjugation (i.e. 
covalent conjugation) or another method for non-covalent conjugation, like the method 
described in Chapter 2, can be used to ensure that most of the AuNPs are covered with 
the protein.  For the 40 nm AuNPs, stoichiometry results in ~5 antibodies on average per 
AuNP, which suggests the assay has a nanoparticle size dependency.   
After the conjugation, UV-Vis spectroscopy and DLS measurements confirmed 
that the AuNPs had antibody on the surface (Figure 3.2 and 3.3). The characterization of 
the adsorption of the antibody could be evidenced in the infrared shift and the increase on 
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hydrodynamic radius of the gold nanoparticle in 4 nm on average. This suggests that the 
position of the antibody might be tilted and not at 90˚ with respect to the AuNP (Ijeh, 
2011). If the antibody would have been perpendicular to the AuNP, the hydrodynamic 
radius measurement would increase about 7 nm. This tilted position might be exposing 
one of the two epitopes present in the antibody to a greater degree. The arrangement of 
the antibodies on the surface of the AuNP could contribute to a decrease in sensitivity. 
The method used in this study to adsorb the antibodies on the surface on the AuNP does 
not show a preference for any position of the antibody. Hence, one of the regions 
interacting with some of the antibodies could be the epitopes, making difficult the 
recognition of its antigen. There are other methods that have improved this interaction, 
making it directional and preferential for the constant region of the antibody (Fc) (Kumar, 
Aaron, & Sokolov, 2008). 
The influence of important factors such as pH, presence of other components and 
preparation of the AuNPs can be crucial when determining which is the best method to 
detect changes in the optical properties of the AuNPs due to the presence of the virus. 
Figure 3.5 and 3.6 showed that the most suitable pH at which the conjugated AuNPs are 
most stable is between 6.5 and 7. This is an advantage because clinical samples would be 
serum samples, which have a pH near 7. The presence of other components like red 
phenol was affecting the UV-Vis measurements, especially because of its absorbance 
peak around 524 nm. This absorption overlaps with the regions studied as seen in the 
blank sample (Figure 3.4). After obtaining this result, the virus was harvested in vitro in 
PBS + 5 % FBS, which doesn’t have high amounts of components that would affect the 
UV-Vis measurements. Another factor that showed interference with the stability of the 
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conjugated AuNPs was the blocking agent used at the beginning of the study. Depending 
on the amount of blocking agent used, this could block epitopes of the antibody 
preventing interactions with the target. This suggested that the use of a blocking agent is 
not always needed, but it can prevent possible unspecific interactions of the virus 
particles and the AuNPs. 
The conjugated AuNPs in the presence of virus produces fluctuations in the 
optical properties and do not show a steadily increasing or decreasing trend. These 
fluctuations may be because sample analysis to detect virus using antibody conjugated 
AuNPs and UV-vis spectrophotometry possibly has low sensitivity compared to the 
plaque assay, a classical technique to determine plaque forming units (PFU) (Ahmed et 
al., 1984). Another disadvantage of UV-vis spectrophotometry is the need for large 
amounts of sample (~500 µL). One of the reasons there is no clear trend when adding the 
virus is the region of wavelengths that is being studied. Although the changes in the 
plasmon peak did not show a conclusive trend, the region of 640-690 nm did show signs 
of aggregation (increased light extinction) when the highest concentration of virus is 
exposed to the conjugated AuNPs. Compared to the plasmon peak, this region may be 
more appropriate to analyze the antibody-antigen interaction.  
On the other hand, DLS measurements of the hydrodynamic radius when the 
conjugated AuNPs were exposed to the virus show no changes comparing to the 
hydrodynamic radius of the conjugated AuNPs. This suggests that the virus might be 
surrounding (“hugging”) the AuNPs and the light scattered is not showing a linear 
binding (AuNP-antibody-virus), but is only showing the virus. Another possibility is that 
the antibody that is conjugated by electrostatic interactions to the gold nanoparticle has 
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changed conformation due to new interactions with the gold nanoparticle. This change 
has been observed in other proteins when conjugation has been by non-covalent 
interactions (Singh, Nagappan Nair, & Aradhyam, 2013; Tsai et al., 2011). If this is the 
case, then the recognition of virus particles cannot take place because epitopes recognize 
the target protein mainly by conformation. To further test this hypothesis, it is 
recommended to perform an ELISA assay with conjugated gold nanoparticles and 
confirm that the interaction antigen (virus protein)-antibody is still present. If there is a 
change in conformation, it is suggested to use another type of conjugation and avoid 
direct interaction with the AuNP.  
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Chapter 4 
4. ANTIBODY DETECTION USING ANTIGEN CONJUGATED GOLD 
NANOPARTICLES 
4.1 Introduction 
The development of a rapid and accurate means for identifying the cause of a 
systemic infection has been a subject of intense interest due to the need for proper course 
of treatment in order to improve patient outcomes. For tropical regions of the world, there 
is a growing need for accurate diagnoses due to the toll in human and economic terms 
due to endemic diseases caused by mosquitoes. Of particular focus in developing 
countries in the tropical zone where Dengue Fever is endemic, is the ability to ascertain 
whether a patient has contracted Dengue Fever and which serotype (DEN-1, 2, 3, 4 and a 
probable newest serotype DEN-5) is the probable cause of the illness. While symptomatic 
diagnostics play an important role in all febrile disease management, some Dengue Fever 
serotypes are believed to be directly linked to severe courses of infection such as Dengue 
Shock syndrome and Dengue Hemorrhoragic Fever, making early serotype identification 
a potentially valuable tool. Moreover, confirmation of whether the patient has had a prior 
serotype infection (which has also been linked to severe Dengue infection courses) can 
also help to determine whether more aggressive steps should be taken to keep the patient 
hydrated and under hospital care ((WHO), 2009; Da Silva, 2014; Mustafa, Rasotgi, Jain, 
& Gupta, 2015; Tüiskunen-Bäck & Lundkvist, 2013). 
Microscopy techniques using gold and other metallic nanoparticles are popular as 
biosensors for detecting the presence of specific biomarkers on tissue and cell samples, 
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ligands (Driskell, Jones, Tompkins, & Tripp, 2011; Engleienne, 1998; S.-H. Huang, 
2006; X. Huang, Jain, & El-Sayed, 2007). Accompanying these applications, there has 
been much attention paid over the past 25 years to the use of gold nanoparticles in 
solution for molecular detection as a homogeneous phase assay, primarily for antibody 
and nucleic acid based tests (Ghosh & Pai, 2007; X. Huang et al., 2007).  
In order to meet the need for a rapid diagnostic that can be implemented in the 
field and closely based on patient exposure and/or immune response at an early stage of 
patient reported symptoms, a hybrid approach that combines gold nanoparticle conjugates 
used in low-cost paper diagnostics based on lateral flow immunoassay technology with 
high sensitivity in conjunction with a quantitative means for detecting a positive response 
is the subject of this feasibility study. In order to establish a relatively low cost diagnostic 
tool, the hybrid technology described in this chapter builds upon the employment of an 
optical caustic light scattering technology that employs no lenses and does not need 
filters (García, Nuñez, Lastra, & Mujica, 2013). Moreover, the use of battery powered 
LEDs and the deployment of a smartphone to analyze the scattered light are also helpful 
in reducing cost as well as in improving access to the device for low and middle income 
countries.  
To commence a process of verifying the capabilities of the new hybrid technology 
platform in a simulated low resource setting, the first approach was to determine if an 
existing Dengue molecular reagent for gold nanoparticle conjugation in paper assays 
could detect Dengue antibodies with human patient samples using this new hybrid 
technology platform. This direct approach with clinically relevant samples is a faster way 
to determine key parameters such as: (1) size of gold nanoparticle that should be used; (2) 
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stability of the gold nanoparticle conjugates when subjected to transportation and varying 
temperature conditions; (3) whether very small amounts of human serum samples can 
yield reasonable signals; (4) determine the need for additional dilution or blocking steps 
when working with human serum; and (5) whether room or body temperature and 
incubation time generate differences in measurement. These key variables in the use of 
antigen conjugated gold nanoparticles and the effect of both particle size and stability are 
addressed during this study. Results obtained for the development of two specific 
homogeneous assays for detection of anti-BSA and anti-Protein E antibodies using 
conjugated gold nanoparticles of 60 nm nominal diameter are described.  Specifically, the 
study discuss effects the addition of electrolytes to increase sensitivity using the anti-BSA 
homogeneous assay confirmed by ELISA results, and results with the use of multiple 
detection methods, light extinction, light scattering and optical caustic sensor, with 
confirmation of microplate results of the surface-bound protein and antibody system. 
Since the plasmonic response of gold nanoparticles is relatively well-understood and 
there are simple online simulators based on Mie Theory, numerical simulations were used 
to provide additional verification of the consistency.  
Thus, the overall objective of this feasibility study is solely to gain experience in 
practical aspects of developing a rapid and hybrid quantitative homogeneous assay for 
detection of antibodies in serum. This case in specific studies the determination of 
Dengue infection by monitoring patient antibody response to Dengue antigens while 
simulating a low resource setting in order to expand testing in a variety of locales and 
with a wider variation in infrastructure than is normally the case in high income country 
clinics and hospitals. 
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4.2 Materials and Methods  
4.2.1 Buffers and Protein Solutions 
Phosphate Buffered Saline (PBS) with 0.2% sodium azide, acetate buffer (pH = 
5), and sodium chloride (5 M) were prepared. Bovine Serum Albumin (Boston 
Bioproducts, Ashford, MA https://bostonbioproducts.com) was dissolved in freshly 
prepared pH = 5 acetate buffer (Fisher Scientific, Pittsburgh, PA 
https://www.fishersci.com/us/en/home.html) to create a stock solution of 10 mg/ml BSA. 
Recombinant DENV-2 Envelope Protein 32 kDa produced in E. coli (Reagent Proteins, 
San Diego, CA http://www.reagentproteins.com) was purchased with a concentration of 
0.96 mg/ml. The solution was diluted in acetate buffer to prepare BSA binding titration 
experiments. 
Polyclonal anti-BSA antibody from rabbit (Rockland Immunochemicals, 
Lemerick, PA https://www.rockland-inc.com/) was diluted with PBS containing azide to 
create a stock solution of 0.1mg/ml.  The stock solution was diluted with PBS containing 
azide to obtain different solutions (10, 5, 1, 0.1 and 0.01 µg/ml) in order to prepare 
samples for ELISA and gold nanoparticle assays. Polyclonal anti-Envelope protein 
antibody from goat (1 mg/ml) was diluted with PBS containing azide to obtain different 
solutions (10, 5, 1, 0.1 and 0.01 µg/ml) for the gold nanoparticle assays. Lyophilized 
human serum (Rockland Immunochemicals, Lemerick, PA https://www.rockland-
inc.com/ ) was reconstituted in PBS containing azide. 
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4.2.2 Attachment of the Antigen to Gold Nanoparticles 
In a 1.5 ml Eppendorf tube, an aliquot of 1 ml containing 9 x 1010 particles per ml 
of 40 nm and 2.6 x 1010 particles/ml of 60 nm gold colloids (Ted Pella Inc, Redding, CA, 
http://www.tedpella.com) were combined with 10 microliters of freshly prepared pH = 5 
acetate buffer prior to the addition of 100 microliters of from 0.1 - 10 mg/ml bovine 
serum albumin depending upon whether coverage at the titration point or at 90 % of 
expected surface saturation was the objective.   A frozen cold pack was placed on the 
tube and the mixture was gently rocked using an orbital table for 30 minutes as a practical 
incubation time for BSA binding. 
After 30 minutes of incubation, 2.5 µl of a 10% solution of Tween 20 (Sigma-
Aldrich Corp., St. Louis, MO http://www.sigmaaldrich.com) was added to the mixture, 
and the mixture was rocked again for 5 minutes. For each particle size, three 
centrifugation steps were conducted in order to reduce the concentration of BSA not 
bound to gold nanoparticles.  The centrifugation conditions used were adapted from 
Cytodiagnostics Inc. (www.cytodiagnostics.com) recommended conditions.  A Beckman 
Coultor Microfuge 18 was placed in a 4 ˚C environmental room in order to minimize 
aggregation of gold nanoparticles and ensure re-suspension after centrifugation.  
For 60 nm gold colloids, the first centrifugation was for 30 minutes at 3500×g.  
Immediately after centrifugation, as much of the supernatant as possible was carefully 
removed from the pellet.  Once this was accomplished, 1 ml of pH = 5 acetate buffer was 
added to re-suspend the pellet.  2.5 µl of 10% Tween 20 was then added to the suspension 
and the mixture was gently rocked for 5 minutes.  Afterwards, the suspension was 
centrifuged again for 15 minutes at 3500×g.  The same procedure was used following the 
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second centrifugation as the first.  For the 3rd centrifugation, time was shortened to 10 
minutes.  After the third and final centrifugation, the pellet was resuspended in 1 ml PBS 
buffer with azide in preparation for the gold nanoparticle immunoassays.  
In the case of protein E, after the third centrifugation step, 500 µl of a solution of 
BSA 0.2 mg/ml in DI H2O were used as blocking agent. After rocking for 5 min on ice, 
500 µl of PBS were added. 
4.2.3 Detection of Antibodies by ELISA  
Wells of polystyrene microtiter plates were coated for 2 h at room temperature 
with different BSA solutions: 5 µg/ml BSA/0.25% of Tween 20, 5 µg/ml BSA/0.5 M 
NaCl, 10, 5, 1 and 0 µg/ml in either 0.1 M sodium carbonate-bicarbonate buffer (pH = 
9.6) or in acetate buffer (pH = 5).  
Plates were washed twice with PBS/0.05% Tween 20 and aspirating the contents. 
Residual binding sites were saturated by incubation with blocking buffer (5% non-fat dry 
milk in PBS/0.05% Tween) for 1 hr at 4 ˚C, followed by two washes of diH2O. 50 µl of 
each antibody solution (10, 5, 1, 0.1 or 0.01 µg/mL) diluted 1/40 in blocking buffer were 
added to each well and incubated for 1 hr at 37 °C. Unbound antibody was removed by 
washing 3 times with PBS/0.05% Tween 20, and 50 µl of goat anti-rabbit IgG peroxidase 
conjugate (Alpha Diagnostic International Inc, San Antonio, TX http://www.4adi.com) 
diluted 1/1000 in blocking buffer was added to each well. Plates were incubated for 1 hr 
at 37 °C and washed 3 times with diH2O. Bound peroxidase was determined adding 100 
µl SigmaFast OPD (Sigma-Aldrich Corp., St. Louis, MO http://www.sigmaaldrich.com) 
substrate. Optical density was read at 490 nm and compared to the negative control 
(uncoated wells).  
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4.2.4 Testing of Human Serum Samples 
All human serum samples were obtained voluntarily from Hemolab S.A. and the 
Lab of Arbovirology of the Universidad Autonoma de Yucatán collected for previous 
studies. Two 6 ml bottles of conjugated gold nanoparticle reagent GNP-60-E were 
created according to the protocol above except that while one GNP reagent (GNP-60-E-
3) was centrifuged 3 times to remove unbound Envelope Protein, a second reagent (GNP-
60-E-1) was centrifuged only once. Both reagents were stored for 16 hours at 4 ˚C then 
transported at room temperature for 19 hours, until refrigerated at 4 ˚C at the Universidad 
Autónoma de Yucatán (UADY). Both GNP-60-E reagents arrived un-aggregated at 
UADY based on both Nanodrop spectrometer (Bio Rad Laboratory, Hercules, CA) 
visible spectra taken at the Universidad Autónoma del Yucatán (UADY) before using the 
reagents and by visual observation of the gold nanoparticle suspension. 
For each test, in a 1.5 ml Eppendorf tube, 900 microliters of PBS was combined 
with 10 microliters of the gold nanoparticle conjugate followed by the addition of 5 or 10 
microliters of the human serum or PBS negative control samples. 
For the testing at 37 ˚C, GNP-60-E-3 was used and 10 microliters of undiluted 
human serum was added. Incubation was performed for 30 minutes at 37 ˚C without 
agitation. Afterwards, each test sample was placed in an oblate spheroid chamber and 
capped, followed by imaging with the smartphone sensor. 
For the first trial at 22 ˚C, GNP-60-E-3 was used and 5 microliters of undiluted 
human serum was added. Incubation was performed for 15 minutes at 22 ˚C without 
agitation. Afterwards, each test sample was placed in an oblate spheroid chamber and 
capped, followed by imaging. 
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For the second trial at 22 ˚C, GNP-60-E-1 was used and 2 microliters of 1:10 
diluted human serum was added. Incubation was performed for 15 minutes at 22 ˚C 
without agitation. Afterwards, each test sample was placed in an oblate spheroid chamber 
and capped, followed by imaging. 
4.2.5 Smartphone Optical Caustic Light Scattering Sensor 
A previously described smartphone-enabled optical caustic light scattering sensor 
was used to capture images of samples in an oblate spheroid chamber [1]. A 532 nm 
green Photodiode (Industrial Fiber Optics, Tempe, AZ) illuminated the sample chamber 
at a 90˚	 angle from a Nokia Lumia 920 (Nokia, Espoo, Finland) smartphone camera lens. 
Images were collected at 0.5 second exposure using the Lumia camera app. At this 
exposure level, and with the intensity of light used, the green channel of the RGB images 
saturate. However, excess light due to scattering can be imaged in the center of the 
sample chamber by splitting the color channels using ImageJ (NIH, Bethesda, MD). 
ImageJ software was used to collect the intensity of the red and blue channels for each 
image. Integrated density measurements from ImageJ was collected for a constant image 
area and used to quantify the amount of scattering observed for gold nanoparticles in 
water, conjugated gold nanoparticles with a serum sample, or Phosphate Buffered Saline 
(PBS) control. 
4.2.6 UV/VIS Spectroscopy and Light Scattering 
An Ocean Optics Fiber Optic Spectrometer  (Ocean Optics, Dunedin, FL, 
http://oceanoptics.com) was used for UV/VIS spectra acquisition using a USB4000 
spectrometer and SpectraSuite Software for control and data acquisition.  A quartz 
cuvette of 1 cm path length was used to acquire samples.  Two different light sources 
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were used for measurements.  For UV detection and standard VIS spectroscopy, a 
Deuterium Halogen light source was employed.  For higher resolution visible 
spectroscopy, a 12 W 350 mA (Titanium) LED source was used.  Since the cuvette has 
all four windows clear for measurement, a InPhotonics 532 nm laser with an Ocean 
Optics controller was in a 90 degree configuration from the fiber optic collector to 
measure counts of scattered light.    
Spectra for UV/VIS data collection was generally collected between 10-100 
milliseconds integration time and 20-100 spectra were averaged for each sample, 
depending upon the light source.  No special temperature stabilization was made for the 
optical systems, so the drift in spectral recordings was negligible.  For the light scattering 
experiments, readings over 1 second of integration and only 2 spectra were used for 
averaging. 
4.2.7 Mie Theory-Based Numerical Simulations 
All Mie theory calculations for light extinction and light scattering were made 
with the Mie theory calculator from nanoComposix website 
(http://nanocomposix.com/pages/tools).  
 
4.3 Results 
4.3.1 Detection of Gold Nanoparticles 
Before interpreting visible light extinction spectra and static light scattering data 
in order to test the antibody immunoassays, a series of tests were done to compare results 
using citrate stabilized gold nanoparticles of different sizes with predicted behavior based 
on the Online Mie Theory Calculator.   
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These calculations were obtained using both the Raleigh approximation of the 
Mie theory for light scattering of smaller particles, and the Guinier approximation for 
larger particles (Mie, 1908; Ringe, Sharma, Henry, Marks, & VanDuyne, 2013; Sorensen, 
2013). Using the Mie theory calculator the light extinction of the different systems used 
in this study could be predicted. Calculations assumed the concentrations provided by the 
manufacturer were correct and the total surface area of gold nanoparticles was used to 
generate graphs that were compared to the experimental results. Figure 4.1 shows that for 
visible light extinction, there is relatively good agreement between the raw data collected 
by the spectrometer and the online Mie Theory calculator values.  There are three main 
similarities that are relevant to subsequent use of light extinction to interpret 
immunoassay test results.  First, the extinction maxima shift to higher wavelengths and 
increases in intensity in both theoretical calculations and experimental results.  Second, 
the lower wavelength extinction values are roughly grouped into 5 different levels.  
Lastly, the three largest sized nanoparticles do not have extinction curves that approach 
zero at 750 nm.   
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Figure 4.1. Predicted and Experimental Light Extinction from Gold Nanoparticles of 
Different Sizes.  
Extinction measurement of gold nanoparticles with equal gold concentration, but size 
varying as shown: 20, 40, 50, 60, 80, 100, 200 nm.  A). measured using a visible light 
spectrometer, and B). from calculations from the Nanocomposix web site 
http://nanocomposix.com/pages/tools  
 
A basis of comparison for static light scattering between the theoretical 
calculations and the 532 nm green laser 90 degree scattering used experimentally is not 
straight-forward, due to the manner used in collecting scattering and recording counts.  In 
order to interpret the theoretical predictions, it is also useful to introduce limits based on 
scattering regimes that predominate in particles ranging from 20 – 200 nm in diameter.  
Figure 4.2 is a graphical representation of calculations, correlations, and theoretical 
model limits.  The main graph shows the relative scattering intensity versus particle 
diameter in a double log plot in order to ascertain trends more easily.  Superimposed on 
the individual calculator predictions are curves showing functional curve fits for the 
limits of Rayleigh scattering dependence (for kR <<1) and the Guinier regime (for kR ~ 
1), where k is the wave vector magnitude and R is a typical dimension of the scatterer.  
The inset shows the Online Mie Scattering extinction (contribution of scattering to the 
absorbance measured) due to scattering at 532 nm versus the experimentally measured 
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scattering counts. As expected, there is a reasonably strong correlation between these and 
the relationship is linear because the limit of small particles (< 20 nm) is zero for both 
scales and the upper limit of all extinction due to scattering is not approached at this 
wavelength for the maximum particle size used.  For the purpose of comparison and 
interpretation, the correlation shown in the inset is useful for predicting the expected 
increase in static light scattering measured with small aggregates. 
 
Figure 4.2. Relative Scattering Intensity of Gold Nanoparticles of Different Sizes.  
Mie Scattering calculations from the Nanocomposix web site for 20-200 nm gold 
nanoparticles are shown along with the Rayleigh Scattering limit (kR<<1) and the 
Guinier regime (kR~1) for comparison.  The inset shows the same Mie calculations in 
terms of the fractional contribution to light extinction measured as “absorbance” on the 
horizontal axis versus the 532 nm scattering at 90 degrees count peak heights. 
 
4.3.2 Anti-BSA Assays 
The next step to optimize was the detection step, which includes the addition of 
electrolytes before incubation with the sample and the incubation temperature with the 
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sample. To determine the sensitivity of the BSA conjugated gold nanoparticles and the 
optimal conditions to detect anti-BSA antibody, different concentrations of anti-BSA 
antibody (0.01-10 µg/ml) with different concentrations of BSA (10, 5, 1 µg/ml, 5 
µg/ml/0.25% Tween 20 and 5 µg/ml/0.5 M NaCl) were tested using an enzyme linked 
immunosorbent assay (ELISA). Figure 4.3 shows that optimal results of antibody-antigen 
interaction obtained were using a 5 µg/ml solution of BSA in the presence of 5 M sodium 
chloride for coating. From the other conditions for optimal antibody-antigen interaction, 
only 1 µg/ml of BSA coating could induce a measurable interaction with respect to the 
negative control. The presence of Tween 20 in the BSA solution did not have an effect in 
the interaction between the antibody and the antigen respect to the negative control and 
other concentrations of BSA coating did not show any significant difference with respect 
to the negative control. The limit of detection of antibody for the BSA solution with NaCl 
was between 1-5 µg/ml of antibody anti-BSA.  
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Figure 4.3. Antibody Detection Through ELISA Under Different Conditions.  
Microplate results of ELISA with different coating concentrations of BSA (1, 5 and 10 
µg/mL) with electrolyte or detergent (Tween 20) addition, testing for detection of a range 
of antibody anti-BSA concentrations (0-10 µg/mL).  
 
To analyze the detection of antibodies anti-BSA with the conjugated gold 
nanoparticles, based on the results obtained with the ELISA, 100 µl of 5 M NaCl were 
added to the conjugated gold nanoparticle solution previous to the addition of the 
antibody. Static light scattering and visible light extinction of each sample were measured 
immediately after the addition of the antibody to monitor changes on the surface of the 
conjugated gold nanoparticles, presumably caused by the antibody-antigen interaction. 
Figure 4.4 shows how visible light extinction spectrum increases with the increasing 
addition of antibody (0.01-0.5 µg/ml). As higher amounts of antibody are added, the light 
extinction decreases again close to the control (1-10 µg/ml). This tendency was also 
reflected in static light scattering measurements as seen before in other experiments 
(Figure 2.2).  
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Figure 4.4. Antibody Detection of Conjugated AuNPs at Room Temperature. 
Light extinction at RT after 0 min of addition of different concentrations of antibody (0-
10 µg/ml). 
 
4.3.3 Dynamic Light Scattering for Insights into Anti-BSA Assays 
Once it was established that there is a change in SLS and visible light extinction 
of conjugated gold nanoparticles in the presence of antibody, dynamic light scattering 
(DLS) was used for confirmation of the antibody-antigen interaction. DLS of gold 
nanoparticles from the manufacturer suggests a nominal diameter of 65 nm (Figure 4.5), 
but the intensity distribution (Khlebstov & Khlebstov, 2011) appears to be relatively 
broad with a significant tail towards larger sizes. In sharp contrast, BSA attachment 
appears to significantly narrow the distribution and increase the mean diameter to 
approximately 80 nm.  The intensity distribution change of about 15 nm in diameter 
appears to be with expected values (Doak, Gupta, Manivannan, Ghosh, & Kahol, 2010; 
Haiss, Thanh, Aveyard, & Fernig, 2007; Khlebstov & Khlebstov, 2011) and the 
stabilization and uniformity generated by the process of protein coating and 
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centrifugation with a surfactant is expected.  However, it should be noted that for a 
second BSA conjugated gold nanoparticles sample, some particles > 4,000 nm were 
detected at relatively low intensity.  This result is corroborated with static light scattering 
measurements, which indicate that this sample scatters significantly more than the other 
sample even though conditions to prepare them were identical. 
 
Figure 4.5.  Diameter of Conjugated and Unconjugated AuNPs.  
Dynamic Light Scattering intensity distribution measurement of 60 nm Gold 
Nanoparticles as is from the manufacturer and after processing to create a coating of 
BSA.  
 
DLS intensity distributions were also measured for 60 nm gold nanoparticles with 
bound BSA and exposed to varying concentration of anti-BSA antibodies from 0-10 
micrograms per ml.  These analyses can yield reports of relatively large aggregates even 
with no addition of antibody and were confirmed by the extinction and static light 
scattering results.  It appears that leaving the gold nanoparticles in the presence of the 
antibody overnight at 4 ˚C can reverse aggregation. Interestingly, when the 
hydrodynamic radius of different gold nanoparticle sizes are plotted for the highest 
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intensity regions, in general the distributions shift to higher sizes and the distribution 
broadens when the particle are equilibrated to higher concentrations of anti-BSA 
antibody (Figure 4.6).  The sole result that does not conform to the trend seen in Figure 
4.6 is for a sample of 5 µg/ml of anti-BSA antibody, but that sample contained significant 
levels of a population of very large (~4,000 nm) diameters. 
 
Figure 4.6.  Particle Size of Conjugated AuNPs in Presence of Antibody. 
A) Cartoon of the hypothesis of the behavior of the BSA system when the amount of 
antibody added to conjugated AuNPs increases. B) Graph of highest intensity 
distributions from dynamic light scattering results for anti-BSA assays with antibody 
concentrations ranging from 0 – 10 µg/ml.     
 
4.3.4 Anti-Protein E Assays In Vitro  
To confirm the behavior of the system observed with BSA conjugated gold 
nanoparticles, protein E conjugated gold nanoparticles were mixed with different 
concentrations of antibody anti-protein E (0.01-10 µg/ml) and static light scattered was 
measured. Figure 4.7 shows that more light is scattered in the presence of increasing 
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amount of antibody except for the curve of 1 µg/ml, which decreased the intensity with 
respect to 0.5 µg/ml.  
 
Figure 4.7. Antibody Detection in vitro Using Light Scattering Intensity Counts.  
Light scattered of Green light LED at 532 nm by protein E conjugated gold nanoparticles 
in the presence of different concentrations of antibody anti-protein E (0-10 µg/ml). 
 
The utility of conjugated nanoparticles is most likely in analysis of serum samples 
from patients, which would have more components such as other antibodies or 
complement protein, which may affect results differently than the system tested in vitro. 
To determine the effect of serum components in SLS and visible light extinction, 
lyophilized human serum was reconstituted and spiked with a known concentration of 
antibody was added to protein E conjugated gold nanoparticles. Visible Light extinction 
spectra and static light scattering were measured for samples spiked with different 
antibody concentrations and a reconstituted serum sample without antibody, as a negative 
control. Figure 4.8 shows that there is a considerable difference in both light extinction 
(Figure 4.8A) and light scattered (Figure 4.8B) by the gold nanoparticles in the presence 
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of antibody at concentrations equal to or higher than 0.5 µg/ml. This observation shows 
that the gold nanoparticles can effectively detect levels of antibody anti-protein E 
specifically, despite the presence of other components of human serum. 
 
Figure 4.8. Antibody Detection in Reconstituted Human Serum. 
A). Light extinction of Protein E conjugated gold nanoparticles in the presence of 10 
µg/ml of antibody anti-protein E in human serum, and B). Light scattering of Protein E 
conjugated gold nanoparticles in the presence 0-10 µg/ml of antibody anti-protein E 
diluted in human serum. Negative control was human serum. 
 
4.3.5 Detection of Anti-Protein E Antibody in Human Serum Samples 
The initial challenge lay in interpreting patient results without an extensive study 
of the antigen protein structure nor its immunogenic properties when presented on gold 
nanoparticle surfaces. This makes discerning the performance of the tests with respect to 
patient Dengue status characterization challenging. The challenge is somewhat reduced 
by using a dot blot test with the same patient samples and gold conjugate reagents as an 
orthogonal test. Table 4.1 provides information on the 10 patient serum samples donated 
by the Arbovirus laboratory of UADY for this study. These samples represent a spectrum 
of patients including Dengue negative, Dengue serotype 2 positive with a first time 
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(primary) infection and 2nd time (secondary) infection, patients convalescing from a 
Dengue serotype 2 infection, and patients with Dengue serotypes 1 and 3 respectively.  
 
Table 4.1. Description On Dengue Status of Human Serum Samples Used in the 
Feasibility Study. 
Patient Dengue Status Primary or Secondary Infection Stage of Disease 
1 Negative N.A. N.A. 
2 Negative N.A. N.A. 
3 DENV-2 Primary Initial stage 
4 DENV-2 Primary Initial stage 
5 DENV-2 Secondary Initial stage 
6 DENV-2 Secondary Initial stage 
7 DENV-3 Unknown Initial stage 
8 DENV-1 Unknown Initial stage 
9 DENV-2 Unknown Convalescing > 120 days 
10 DENV-2 Unknown Convalescing > 120 days 
 
Before conjugation of Protein E to gold nanoparticles, the choice of gold 
nanoparticle size was deemed to be a key variable that needed to be determined. Based on 
the well understood properties of gold nanoparticles to light scattering via plasmon 
resonance (Fan, Zheng, & Singh, 2014) near the maximum for spheres of 520-540 nm, a 
calibration was conducted with a laser light scattering fiber optic spectrometer, the 
optical caustic sensor, and calculations based on Mie Theory (Fan et al., 2014; 
nanoComposix, 2016). Figure 4.9 illustrates two key points. First, that the laser light 
scattering system which is based on 90 degree scattering is sensitive to small changes in 
particles size at a narrow range of between 30-70 nm diameter particles. Mie Theory 
calculations illustrate that the total scattering for gold nanoparticles increases more 
gradually with size, since this calculation takes into account all angles of scattering. The 
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Optical Caustic sample chamber is seen in Figure 4.9 to fall between the two groups of 
data, using both a camera and a digital color sensor to collect data. It was also found that 
the red channel of the smartphone RGB image was most useful based on the LED 
intensity and shutter speed setting since smartphone sensor saturation “bleeds” signal to 
the red and blue channels when there is an excess of green in the image. The digital color 
sensor corroborates that interpretation, as shown in Figure 4.9. 
 
Figure 4.9. Relative Scattering Signal Through Different Methods of Different AuNP 
Size. 
Comparison of gold nanoparticle scattering with green light data for a laser and fiber 
optic spectrometer, LED/optical caustic smartphone, and LED/optical caustic digital 
color sensor.  Discrete calculations of the total scattering at 532 nm using Mie theory is 
also shown.  Data and calculations are normalized to the maximum value for gold 
nanoparticles of 200 nm and fitted to a logistic curve.  Horizontal dashed lines illustrate 
the signal difference for 60 and 120 nm diameter gold nanoparticles. 
 
Before commencing patient testing, the 60 nm gold conjugates were inspected and 
the UV/VIS spectra were recorded for the two batches of particle conjugates (Figure 
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4.10). Both visual and spectral information verified that the gold conjugates were stable 
and ready to use at UADY. 
 
 
Figure 4.10.  Nanodrop Spectrometer UV/VIS Spectrum of Conjugated AuNPs.  
The absorbance in the UV is due to the BSA blocking solution.  The absorbance maxima 
at a wavelength of 540 nm is consistent with the expected plasmon resonant peak for 
conjugated gold nanoparticles of 60 nm diameter. 
 
Table 4.2 summarizes the expected dot blot score based on the protein E gold 
conjugate reagent (GNP-60-E-3) used, assuming some level of cross-reactivity with other 
Dengue serotypes and a 50% probability of measuring antibodies reactive to Protein E 
after 120 days of convalescence. The individual blot samples and the scores of the dot 
blot are shown in Table 4.2. Overall, the agreement is very good. However, the two 
dengue negative patients appear to give positive dot blot results.  
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Table 4.2. Comparison of Dot Blot with Result Reported by the Clinical Laboratory.  
Patient 
Expected Dengue Result Based on Dengue 
Serotype and Some Cross-Reactivity 
(assuming high sensitivity to IgM) 
Dot Blot Score ( + or -) Agreement 
1 - + NO 
2 - + NO 
3 + + YES 
4 + + YES 
5 - - YES 
6 - - YES 
7 - - YES 
8 + + YES 
9 + + YES 
10 - - YES 
The Protein E used while specific for DENV-2, has sensitivity for IgM detection and can 
have cross-reactivity with other serotypes. 
 
A summary of the three sets of tests with human serum samples and an overall 
score is given in Table 4.3, while a quantitative comparison of the dot blot is shown in 
Figure 4.11. The overall score given in Table 4.3 is based on assessing the differences 
among the three tests using gold nanoparticles made with either 3 or 1 centrifugation 
step(s) and at different times and temperatures. Based on the results in Table 4.3, it 
appears that the results with GNP-60-E-1 at 22 C for 15 minutes seem to be most closely 
related to the characterization based on the dengue patient status information.  
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Table 4.3. Qualitative Summary of Optical Caustic Scattering Smartphone Sensor Data. 
Patient GNP-60-E-3 37 C for 30 min 
GNP-60-E-3 
22 C for 15 min Trial 
1 
GNP-60-E-1 
22C for 15 min 
Trial 2 
Overall 
Score (+ or -) 
1 weak positive positive negative - 
2 positive negative positive + 
3 positive positive positive + 
4 positive positive weak positive + 
5 positive positive positive + 
6 positive negative positive + 
7 negative weak positive negative - 
8 positive positive negative - 
9 positive weak positive positive + 
10 very weak positive positive positive + 
PBS 
Control negative negative negative 
NEGATIVE 
CONTROL 
PBS 
Control negative negative negative 
NEGATIVE 
CONTROL 
 
In Table 4.5, there are two overall features to note. First it appears that the 
smartphone signal saturates at low “signals” from the dot blot experiments. The second 
feature is that the negative control and patient sample 10 are both low for the dot blot and 
the optical caustic sensor, but there is disagreement between patient samples 5 and 6 
between the two detection methods.  
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Table 4.5.  Comparison of Dot Blot and Optical Caustic Smartphone Sensor.   
Patient Initial Information 
Clinically 
expected result Dot blot 
AuNP-60-E-1 22 C 
for 15 min 
1 Negative - + - 
2 Negative - + + 
3 DENV-2 (1ary 
infection)  + + + 
4 DENV-2 (1ary 
infection) + + + 
5 DENV-2 (1ary 
infection) - - + 
6 DENV-2 (1ary 
infection) - - + 
7 DENV-3 - - - 
8 DENV-1 + + - 
9 DENV-2 + + + 
10 DENV-2 - - + 
PBS control N.A. N.A. N.A. - 
PBS control N.A. N.A. N.A. - 
Data were recorded at the same sample incubation temperature of 37 ˚C. 
 
4.4 Discussion 
One of the more interesting results from our experiments and analyses was in 
understanding gold nanoparticle changes in the homogeneous immunoassays by 
comparing visible extinction, static light scattering, and dynamic light scattering data.  
Also valuable as a guide in selecting conditions and interpreting results were the 
predicted results obtained with the Online Mie Scattering Calculator (nanoComposix, 
2016).  Specifically, the calculator was helpful in selecting the appropriate gold 
nanoparticle size and providing a better understanding of the visible extinction data for 
the immunoassay measurements since the changes can be subtler near the plasmon 
resonance peak.  In contrast, the research literature (Doak et al., 2010; Driskell et al., 
2011; Raj & Sreenivasan, 2010; Thanh & Rosenzweig, 2002) generally provides only one 
 69 
detection method per article and rarely compares experimental information with 
theoretical results that are readily accessible to the reader.   
At times it can be difficult to comprehend the way that extinction data is 
interpreted in numerous articles due to a number of calculations done to the raw data.  
While spectra normalization (Amendola & Meneghetti, 2009) and calculating the ratio of 
2 wavelengths for extinction or scattering results (Haiss et al., 2007) can lead to a useful 
way of calibrating instruments, these methods also obscure how the entire raw spectra 
can provide important clues on aggregation before, during or after homogeneous 
immunoassays are conducted. As seen in Figure 4.1, there are changes in extinction al 
wavelengths below the plasmon peak for particles of different diameters.  Immunoassay 
conditions that lead to a small number of low numbers of particles aggregating will 
increase the extinction near 400 nm as well as increase the tail of the spectrum at 
wavelengths greater than the plasmon resonance peak.  By normalizing the spectra using 
absorbance ratios or matching absorbance at 400 nm, the interpretation of the data can 
also be challenging at low concentrations of gold nanoparticles, since extinction values 
used in normalizing will be low and subject to more experimental uncertainty.  While 
impractical for calibration and routine use of immunoassays for detection, fitting 
predicted extinction curves based on possible aggregate populations to the extinction 
spectra data would nonetheless provide a more mechanistic interpretation of experimental 
and analytical results. 
Another useful illustration of the theoretical calculations is in tracking changes 
from unmodified gold nanoparticles through aggregate populations in immunoassays.  
Using the calculator, it can be clearly seen that a layer or “shell” of protein with a 
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refractive index greater than water will increase overall extinction of light and extinction 
due to scattering.  Since protein layers have been reported to have refractive indices of > 
1.33 (Tsai et al., 2011), gold nanoparticle visible light extinction curves before addition of 
protein should be slightly lower than when protein is bound to the surface.  However, at 
times the extinction and scattering decrease. As noted in Figure 4.5 with dynamic light 
scattering, gold nanoparticle aggregation can be dispersed by the addition of protein.  
Also, unless there is an excessive coating of antibody very much higher than the original 
protein layer, the expected extinction for gold nanoparticle sizes of 60 nm predicted by 
the calculator should not increase substantially.  This is a useful guide to help discern 
small changes in static light scattering or extinction due to antibody binding versus much 
larger changes in the spectra or static light scattering at a specific angle when aggregates 
are formed due to antibody bridging across multiple gold nanoparticles with surface 
protein.   
This behavior was also observed in the BSA conjugated gold nanoparticles 
experiments. In Figure 4.4, both visible light extinction and light scattering increased the 
signal progressively, which would indicate aggregation because of antibody bridging. As 
the antibody concentration increases, it is more probable that two gold nanoparticles are 
not interacting with the same antibody, but that each nanoparticle has interaction with one 
or more antibodies separately from other nanoparticles, observed in less aggregation in 
solution.  
Detecting gold nanoparticle changes using 90 degree static light scattering at 532 
nm proved to be effective and simple, primarily because 60 nm gold nanoparticle 
scattering at this angle is relatively easy to detect and because the measurement is 
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sensitive to small changes in aggregation.  Using a conventional quartz cuvette stage and 
fiber optic detector at 90 degrees from the green laser was sufficient in this system to 
analyze lower particle concentrations than using light extinction.  Of particular value is to 
detect whether the final preparation of gold nanoparticles are aggregated based on the 
size versus scattering prediction given in Figure 4.1.  We found that the reference values 
of no antibody present may be difficult to establish experimentally unless guided by the 
predicted results.  Addition of buffer components to minimize protein-protein aggregation 
or allowing the prepared gold nanoparticles to be stored overnight and removal of any 
precipitate can help establish a true “zero” since even a small population of aggregates 
can increase the scattering significantly.  Usually, once antibody is present in solution, 
those aggregates can tend to dissipate thus lowering the measured scattering and creating 
a problem in data interpretation, which was observed in Figure 4.4 after 30 min at 40 ˚C 
where the tendency was the same, but the intensity decreased.  Testing the conjugated 
gold nanoparticles before addition of antibody for light scattering, so that an expected 
value is achieved, would be a useful step to help obtain more reproducible homogeneous 
assay results. 
Dynamic Light Scattering also demonstrated utility in corroborating aggregation 
and distributions in gold nanoparticles, but there are some challenges in interpreting the 
information.  Khlebstov and Khlebstov (Khlebstov & Khlebstov, 2011) point out that 
there are anomalies when applying DLS to gold nanoparticles.  They suggest using 
intensity distribution rather than number or volume distributions, and our much more 
limited experience with 60 nm gold particles is an agreement with that recommendation.  
As shown in the results section, Figure 4.6 shows a distinct trend in the distribution with 
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higher antibody concentrations for the anti-BSA assay.  The overall trend of a broader 
distribution with a peak maxima shift to higher diameters for higher concentration of 
anti-BSA antibody resembles the trend in weight distribution of polymers for 
polymerizations that follow a Schultz-Flory WCLD.  The probability of increasing 
hydrodynamic radius from DLS measurements with higher antibody concentrations 
suggests that the particle populations follow an increasing probability for longer chains 
and higher dispersity.  This is similar to the weight distribution as predicted in a Shultz-
Flory WCD (Equation 1) for ideal linear step polymerization kinetics (Figure 4.12) 
(Meira & Oliva, 2011).  𝑤 𝑟 = $$% 𝑒' $ $%  (1) 
 
Figure 4.12. Shultz-Flory Distribution of Weight Distribution. 
A normalized Shultz-Flory distribution of weight distribution as a function of mean radii 
(Meira & Oliva, 2011). 
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However, as noted in the results section, the data in Figure 4.6 for 5 microgram 
per ml antibody does not follow the trend due to what appears to be large cluster formed 
rather than a broad distribution.  It seems reasonable to assume that both highly 
distributed and a few highly aggregated populations are possible states given the 
relatively high concentration of antibody as compared to the number of gold 
nanoparticles in the assay. 
The kinetic effect can also be witnessed in the visible light spectra and static light 
scattering results obtained for both systems. The intensity count values for the negative 
control were not always the same. Aggregates are forming at different rates in solution in 
a random process, even before adding the antibody; therefore defining an absolute zero 
cannot be done. This is one disadvantage because each time an experiment is performed, 
a new zero needs to be established.  
On the other hand, the presence of electrolytes in solution can improve the 
antigen-antibody interactions, increasing the signal in static light scattering. In the case of 
the BSA conjugated nanoparticle system, we hypothesize that electrolytes help BSA get 
in a conformation that might be more suitable for the antibody recognition. Nevertheless, 
the addition of electrolytes is not always necessary. Yeo et al. (Yeo et al., 2015) in their 
study with protein E did not use the addition of electrolytes and had successful results, 
which confirm the results obtained in this study.  
When the assay was tested with the human serum samples, the samples were 
obtained from patients with different serotypes and stages of Dengue (Table 4.1). Patients 
with early stage and primary dengue infection should present IgM against dengue 
antigens after a few days of infection and the IgM levels should decrease after 90 days 
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((WHO), 2009; Cuzzubbo et al., 2001; Da Silva, 2014; Lin et al., 2012; Mustafa et al., 
2015; Rosckstroh et al., 2015; Tüiskunen-Bäck & Lundkvist, 2013). Patients with a 
secondary infection should mostly present IgG antibodies ((WHO), 2009; Da Silva, 2014; 
Lin et al., 2012; Mustafa et al., 2015; Tüiskunen-Bäck & Lundkvist, 2013). The antigen 
Protein E used as the reagent conjugated to the gold nanoparticles is a recombinant 
protein with selectivity towards Dengue Serotype 2 antibodies and is described by the 
manufacturer as being most sensitive to IgM levels. However, it is known that there can 
be cross-reactivity to other dengue serotype antibodies as well as from patients who have 
experienced other arbovirus infections from the group known as flaviviruses such as 
West Nile, St. Louis Encephalitis, Zika Virus, and Chikungunya (Cuzzubbo et al., 2001). 
These considerations suggest that there should be some variation in test results, but the 
variations may be difficult to discern without a more comprehensive series of human 
serum controls.  
The cross-reaction could also be observed with the results of the dot blot and the 
optical caustic smartphone sensor. In table 4.2, two dengue negative patients appear to 
give positive dot blot results. It is not clear why this is the case, but perhaps a current or 
prior flavivirus infection is being detected by the gold conjugate reagent. It is important 
to note that the sample with PBS added and no human serum was correctly identified as a 
negative control in the dot blot experiment. It is also important to note that the dot blot 
test with a monoclonal antibody that reacts with flavivirus group specific antigens (4G2, 
KPL) was found to be negative (not shown).  
The negative result observed with the new sensor suggests that epitopes of the 
protein envelope needed for the monoclonal antibody to bind to the GNP-60-E-3 were 
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blocked due to the immobilization of Protein E to the gold nanoparticles (Table 4.3). This 
is a potentially useful observation for further gold conjugate development, namely if a 
methodology for Protein E binding to gold based on covalent attachment rather than his-
tag is used. 
The calibration data determined that using 60 nm gold particles is very practical 
for the intended application (Figure 4.9). The reason for this is that there is a dramatic 
(approximately 340%) increase in signal predicted when two 60 nm gold particles 
aggregate upon antibody-antigen binding, basically the change in relative signal from 60 
nm to 120 nm gold particle size.  
The Optical Caustic Scattering Smartphone Sensor results show that it saturates 
with samples that show low signal with the dot blot, which seems reasonable given the 
high signal change described in Figure 4.9 for aggregates consisting of 60 nm gold 
particles. The disagreements observed between the dot blot and optical caustic sensor 
may be due to the higher sensitivity of the optical caustic sensor as compared to the dot 
blot, which used gold nanoparticles at a higher level of dilution. Dot blots are also 
considered to be lower in sensitivity due to diffusion and orientation effects when binding 
to a fixed surface. 
Another observation is that patient sample 7 yielded a very weak signal and 
patient sample 10 is negative based on the dot blot tests, yet the optical caustic sensor 
data show strong signals. This again may be due to higher sensitivity of the optical 
caustic system and cross reactivity of the Dengue Serotype 2 recombinant Protein E with 
other Dengue serotypes. As noted in the results for GNP-60-E-1 at 22 ˚C and 15 minutes 
seen in Table 4.3, it appears that this cross-reactivity may be diminished by using a 
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higher dilution of human serum, lower temperature, and allowing some unbound antigen 
in the gold nanoparticle conjugation suspension. 
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Chapter 5 
5. SEQUENCE-SPECIFIC DETECTION OF DIFFERENT STRAINS OF LCMV IN A 
SINGLE SAMPLE USING TENTACLE PROBES 
5.1 Introduction 
RNA viruses affect most of the population, especially in developing countries, 
and are the major cause of emerging and re-emerging diseases in humans (Cella et al., 
2013; Holmes, 2009; Marston et al., 2014). One of the most important problems with 
understanding RNA viruses and developing appropriate vaccines/therapies, is their 
propensity for rapid change due to its high mutation rate because of lack of proofreading 
property in the encoded RNA polymerase (Domingo et al., 2012; Marston et al., 2014; 
Moya et al., 2000). High mutation rate rand high replication rate results in quasispecies 
even in a single host (Domingo et al., 2006; Domingo et al., 2012; Lauring and Andino, 
2010; Moya et al., 2000). Presence of quasispecies correlates with enhancement of 
virulence because of the flexibility of the population of the virus to adapt easily with the 
dynamics of the host (Lauring and Andino, 2010). This has been observed in poliovirus, 
where the presence of quasispecies cooperated the entrance of a neovirulent clone in mice 
(Lauring and Andino, 2010), and in evasion of immunity of Hepatitis C Virus (Domingo 
et al., 2006). 
Current diagnostic methods can detect the virus directly, indirectly, fluorescence-
based emerging technologies and immune-based. Indirect detection is achieved by 
detection of virus particles (antigens) or RNA. Some immune-based methods can be non-
specific due to cross-reaction and most of them are expensive and not field-portable 
(Guzman et al., 2010; Peeling et al., 2010). Fluoresce-based are usually molecular 
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procedures that are used to detect RNA using reverse transcriptase PCR (RT-PCR), 
which is sensitive and specific, but is highly prone to false-positive results due to easy 
contamination ((WHO), 2009; C.D.C., 2010). The most common molecular technique is 
using a fluorescent dye that binds to dsDNA and using a calibration curve to quantify the 
amount of DNA.  Another fluorescent-based technique is using probes called molecular 
beacons, which consist in a stem-loop that, when self-hybridized, places the fluorophore 
on the 5' end in close proximity to the quencher at the 3' end thus quenching the 
fluorescence. When the molecular beacon encounters its target, it changes to its open 
conformation and hybridizes with the target leading to the fluorophore to emit a signal. 
Tentacle Probes are modified molecular beacons because they have a single stranded 
DNA attached to the stem-loop by a 9-mer chain of polyethylene glycol (PEG). The ~15 
nt single stranded DNA is called capture sequence because, as it is implied by its name, it 
captures the DNA strand and as a consequence it increases the local concentration of the 
stem-loop around the DNA strand from a range of nM (free probe) to mM (capture probe 
bound), increasing the probability of the stem-loop to bind to the target (Satterfield et al., 
2007a; Satterfield et al., 2007b). This technology was successfully used for the detection 
of Yersinia pestis and Bacillus anthracis using the bacterial DNA (Satterfield et al., 
2007a), but it has not been tested with any RNA organism or virus.  
In this study, we proposed a fast and cost-effective molecular method for 
detection of RNA viruses. For this purpose, a virus model for RNA viruses, Lymphocytic 
Choriomeningitis Virus (LCMV) was used. The method intends to differentiate two 
strains of LCMV: Clone-13, which causes a chronic infection in mice, versus the wilt 
type Armstrong strain, which causes an acute infection in mice. The difference in type of 
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infection is due to a single mutation in the S segment of LCMV, C855T, which is a 
missense mutation observed in an amino acid change in the receptor protein GP1 
(F260L). The proposed method uses Tentacle Probes coupled with qPCR and showed 
that the designed probes to detect Armstrong and Clone-13 strains could differentiate 
them even with only a single mutation in the RNA that was obtained both in vitro and in 
vivo. Results also showed that Tentacle Probes could detect specifically each strain with 
as little as 10 % of presence of one strain in a sample with a mixture of both strains. 
 
5.2 Materials and Methods 
5.2.1 Tentacle Probe Design  
Both Tentacle Probes were designed based on the generalizations of the principles 
described by Satterfield et al. (Satterfield, West, et al., 2007). Briefly, four hundred 
possible combinations of detection probes and capture probes were simulated to obtain a 
suitable probe to detect the strain Clone-13 of LCMV over the Armstrong strain, and vice 
versa for the detection of Armstrong strain. DINAMelt and UNAFold applications 
(Markham and Zuker, 2005, 2008) were used to calculate melting temperatures of the 
detection probe stem, the capture probe-target duplex, and the detection probe-target 
duplex, independent of each other. The targeted single mutation was located in the loop 
of the detection probe. The detection and capture probes were designed with predicted 
melting temperatures around the predicted assay temperature of 60 °C. The melting 
temperature for the stem-loop structure was chosen 7–10 °C above the assay conditions 
(70 °C). The most appropriate probe from the simulated probes with the previous 
characteristics was purchased from Biosearch Technologies as a custom oligonucleotide 
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to use for the detection of each strain (Biosearch Technologies, Petaluma, CA, 
https://www.biosearchtech.com). The calculations obtained for each probe are 
summarized in Table 5.1. 
 
Table 5.1. Probe Sequences for each Strain and their Thermodynamic Parameters 
Calculated.   
Equilibrium constants and ratio of probe predicted to fluoresce for each probe. 
Probe sequence Kstemloop 
KdetectionT 
(µM-1) 
KcaptureT 
(µM-1) 
Fraction of 
fluorophore 
predicted to 
be 
fluorescing 
with Target 
Fraction of 
fluorophore 
predicted to 
be 
fluorescing 
with Non-
Target 
Clone13: 
FAM-
cgtaagTTCCTCTCACGaac
ttcg-BHQ-PEG9-
acattcacctggactttgtcagactc 
62.35 82.53 1.43x108 0.5447 0.0053 
Armstrong: 
FAM-
cgtagtGATTCTTCACtacg-
BHQ-PEG9-
agcgggcacattcacctgg 
26.44 33.93 6.9x109 0.3188 0.0276 
 
5.2.2 RNA Isolation and cDNA Obtention 
RNA isolation from BHK21 cell virus collection in vitro was performed 
following the guanidinine thiocyanate-phenol-chloroform (GNTC) procedure described 
before (Chomczynski & Sacchi, 2006) with some modifications. Briefly, virus 
supernatant was mixed with GNTC in a 1:2 ratio, followed by the addition of 0.1 
volumes of 2 M sodium acetate pH=4, 1 volume of Acid phenol pH=4.3 and 0.3 volumes 
of chloroform-isoamyl-alcohol 24:1 (Sigma Aldrich Inc., St. Louis, MO, 
http://www.sigmaaldrich.com/united-states.html). Samples were centrifuged at 20000×g 
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for 30 min at 4 ˚C, then the aqueous phase was transferred into a new tube and 1.1 
volumes of isopropanol were added and left at -20 ˚C overnight. Next, samples were 
centrifuged at 20000×g for 30 min at 4 ˚C, supernatant was discarded and 1 volume of 70 
% ethanol was added. Another centrifugation step at the same conditions was performed, 
after which the supernatant was removed completely, the tube was air-dried and the pellet 
was resuspended in nuclease-free water. cDNA was obtained in a two-step procedure 
with Omniscript RT kit (QIAGEN, Valencia, CA, https://www.qiagen.com/us/) and 
posteriorly amplifying the fragment with PCR using Phusion® High-Fidelity DNA 
polymerase (New England Biolabs, Ipswich, MA, https://www.neb.com). The primers 
were designed to obtain a 538 nt amplicon of the S segment of LCMV that includes the 
C855T mutation found in Clone-13. These are the following: Forward: 
5’AGCCAGTGTAGAACCTTCAGAG3’ and Reverse: 
5’AGTGGTTCCTCATCAGTAGTTG3’. The cycling conditions for the PCR were the 
following: 30 sec at 94 ˚C, 30 cycles of 20 sec at 94 ˚C, 30 sec at 50 ˚C and 2 min at 72 
˚C, and a final extension of 5 min at 72 ˚C. 
RNA from plaques from a previous plaque assay of unknown samples was 
obtained mixing SM buffer with the extracted plaques and letting them sit overnight at 4 
˚C. Then, RNA was isolated using the RNAqueous® Total RNA Isolation Kit (Thermo 
Fisher Scientific, Waltham, MA, https://www.thermofisher.com/us/en/home.html). All 
RNA concentrations were measured using Nanodrop 1000. cDNA was obtained through 
RT-PCR performed with SuperScriptIII One step RT-PCR system with Platinum® Taq 
DNA polymerase (Thermo Fisher Scientific, Waltham, MA, 
https://www.thermofisher.com/us/en/home.html). Primers used were the same used for 
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the PCR described. The cycling conditions were the following: 30 min at 50 ˚C, 2 min at 
94 ˚C, 35 cycles of 15 sec at 94 ˚C, 30 sec at 55 ˚C and 2 min at 68 ˚C, and a final 
extension of 5 min at 68 ˚C. 
 
5.2.3 Melting Curve and qPCR 
The melting curve from the probe was obtained to determine the temperature at 
which the target and non-target were best differentiated. To a 20 µL reaction with 10 µl 
of the designed tentacle probe (final concentration: 50 nM) and 10 µL either 1 nM of 
target or non-target DNA, fluorescence at 10 ˚C until 90˚C every 0.6 ˚C/sec was 
measured. For the qPCR, the primers were designed to obtain a 150 nt amplicon of the S 
segment of LCMV that contained the C855T mutation found in Clone-13 strain compared 
to Armstrong strain, and are the following: Forward: 
5’CAGGTCCTTTTGGGATGTCCAG3’, Reverse: 
5’CTCTGCAGCAAGAATCATCCATTTG3’. For these experiments a 20 µl reaction 
included we used 1.5 U/rxn of Platinum® Taq DNA polymerase, 0.1 µM of the tentacle 
probe, 0.5 µM of each primer, 5 mM (Clone-13) or 1.5 mM (Armstrong) MgCl2, 1X 
Buffer, 0.2 mM dNTPs and 0.25 nM of DNA (sample, target or non-target). The cycling 
conditions for the qPCR were the following: 2min at 95 ˚C, 40 cycles of 1 sec at 90 ˚C 
and 3 min at 50 ˚C. The mechanism is illustrated in Fig. 1. These conditions were 
standardized for each probe as shown in reuslts. qPCR was performed in a ViiA 7 Real-
Time PCR System from Life technologies (Thermo Fisher Scientific, Waltham, MA, 
https://www.thermofisher.com/us/en/home.html). Each sample was tested at least in 
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triplicate. Raw fluorescence counts per cycle were further analyzed for comparison 
between samples. 
 
 
Figure 5.1. Tentacle Probe Mechanism of Detection of the Target Sequence.  
Adapted from (Satterfield, West, et al., 2007). 
 
5.3 Results 
The differentiation of strains or genotypes of viruses can determine and, in many 
cases, predict the virulence of an infection. In the case of Dengue, for example, it is 
important to determine the serotype as a method of surveillance in the population to try to 
prevent hemorrhagic fevers (Guzman et al., 2010; McCausland and Crotty, 2008; Peeling 
et al., 2010). In the case of LCMV, a different strain or genotype can determine the type 
of infection: chronic (Clone-13) or acute (Armstrong). For this purpose a tentacle probe 
was designed to detect Clone-13 over Armstrong and vice versa. The target mutation is in 
the sequence of the surface protein GP1 (C855T) of the virus that makes an amino acid 
change (F260L) and it is the main determinant for a chronic or acute infection.  The 
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thermodynamic parameters obtained using DINAMelt and UNAFold applications 
(Markham and Zuker, 2005, 2008) were used to calculate the equilibrium constants for 
each one of the hybridization steps of the capture and detection probe described by 
Satterfield et al (Satterfield et al., 2007b), to predict the fraction of probe fluorescing with 
the target or non-target. These predictions helped determine the most suitable 
combination of detection and capture sequence among more than ~400 possible 
sequences that were simulated.  
For the probe designed to detect Clone-13 strain, the calculations predicted that 
the ratio of probe fluorescing with the target would be 54.47 % versus 0.53 % with the 
non-target (Table 5.1). For the probe designed to detect the Armstrong strain the 
percentages were 31.88 % and 2.76 % with the target vs the non-target, respectively. The 
prediction is not accurate because as observed in the melting curve for both probes 
(Figure 5.2), the detection of the non-target was considerably higher than 0.05 % and 
2.76 %. With the thermodynamic calculations it could also be determined the increase in 
the equilibrium constant when it takes into account the hybridization of the capture 
sequence (Table 5.1), rather than when it is not present in the probe such as in molecular 
beacons.  
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Figure 5.2. Melting Curve to Confirm the Annealing Temperature to be Used.  
Determination of the optimal annealing temperature with a melting curve of the A) 
Clone-13 detection probe and B) Armstrong detection probe, to differentiate between 
target and non-target with a melting curve ran at 75 and 750 nM of the initial target or 
non-target DNA. 
 
5.3.1 Melting Curve and Optimization of Conditions for qPCR 
To confirm the overall melting temperature calculated by DINAMelt and 
UNAFold of each one of the probes, a melting curve was performed at different DNA 
concentrations for the target and the non-target in each case. Figure 5.2A shows that the 
best range at which the Clone-13 probe differentiates the target (Clone-13) and non-target 
(Armstrong) DNA is around 40 ˚C, but annealing temperatures in PCR are known to be 
best in the 45-60 ˚C range. For this purpose, qPCRs were performed at 4 different 
annealing temperatures along this range: 45, 50, 55 and 60 ˚C. Figure 5.3A shows raw 
fluorescence counts of the target (solid lines) and non-target (dashed lines) at each 
annealing temperature with the Clone-13 probe. After each cycle it is observed how raw 
fluorescence is increasing Although at each temperature there is a visible difference 
between target and non-target, the best differentiation at maximum fluorescence was 
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observed using an annealing temperature of 50 ˚C with ~1.3 fold of maximum 
fluorescence.  
For the Armstrong probe, Figure 5.2B shows the melting curve for this probe and 
it suggests that the best range at which it can differentiate best target (Armstrong) and 
non-target (Clone-13) DNA is between 40-50 ˚C, but practical limits on cooling make 
those impractical and amplification is less reliable at lower temperatures. Four different 
qPCRs were performed with different annealing temperatures along this range: 42, 45, 48 
and 50 ˚C, and were evaluated for the best differentiation between target and non-target. 
Figure 5.3B shows normalized fluorescence counts to the maximum non-target 
fluorescence at each temperature tested and Figure 5.3C shows raw fluorescence counts 
for the same temperatures. Both graph suggest that the best annealing temperature for this 
probe is 50 ˚C, showing ~1.85 fold of maximum fluorescence for the target versus non-
target. It is important to mention that for this probe it is not observed the exponential 
phase in the fluorescence curves, as it is expected in a qPCR curve, in both raw and 
normalized fluorescence counts (Figure 5.3B and 5.3C). 
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Figure 5.3. Optimization of Annealing Temperature for Clone-13 Probe and Armstrong 
Probe.  
A) Raw fluorescence measured at different annealing temperatures (45, 50, 55 and 60 ˚C) 
of Clone-13 (solid lines) and Armstrong DNA (dashed lines) with the Clone-13 probe. B) 
Normalized Fluorescence to the maximum non-target fluorescence at different annealing 
temperatures (43, 45, 48 and 50 ˚C) of Armstrong (color lines) and Clone13 DNA (gray 
lines) with the Armstrong probe, and C) Raw fluorescence counts at the same annealing 
temperatures of Armstrong (solid lines) and Clone-13 DNA (dashed lines) with the 
Armstrong probe. 
 
For the annealing temperature, all the thermodynamic calculations were based in 
an assay temperature of 60 °C for each probe, although as observed with the melting 
curve for each probe (Figure 5.2), the melting temperature for each was lower than 
expected, and by 60 °C the probe was completely dissociated for both the target and the 
non-target. The best annealing temperature for each probe was chosen because it gave the 
maximum differentiation between target and non-target at the same DNA concentration. 
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After determining which was the optimal annealing temperature to differentiate 
target and non-target DNA, two other parameters were optimized: the optimal initial 
sample DNA concentration for each reaction and the MgCl2 concentration needed in the 
reaction. The concentration of MgCl2 is crucial for the activity of the enzyme and even 
the salt effect on DNA. Three or four concentrations (0.5, 1.5, 3 and 5 mM) were tested 
for best results, including the concentration suggested to use by the manufacturer of the 
enzyme employed. Results showed that for the Clone-13 probe the most suitable 
concentration to use was 5 mM with ~1.4 fold maximum fluorescence of the target vs 
non-target, and for Armstrong probe, the most suitable concentration to use was 1.5 mM 
with ~1.5 fold maximum fluorescence of the target vs non-target (not shown). 
Finally, to determine the minimal concentration at which the fluorescence is best 
for target detection, three initial DNA concentrations were evaluated: 0.1, 1 and 10 nM. 
Figure 5.4A shows the normalized fluorescence counts obtained with different starting 
concentrations of sample DNA for the Clone-13 probe and Figure 5.4B shows the same 
but with the Armstrong probe. Both graphs show that differentiation between target and 
non-target is best when using a sample concentration of 1 nM as a starting DNA 
concentration. Although 10 nM of DNA also showed good results, the best fluorescence 
differentiation between target and non-target is using 1 nM of sample DNA.   
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Figure 5.4. Optimization of Minimum Starting Concentration of DNA in Sample 
A) Fluorescence counts of Clone13 (color lines) and Armstrong DNA (gray lines) with 
different initial DNA concentrations. B) Fluorescence counts of Armstrong (color lines) 
and Clone13 DNA (gray lines) with different initial DNA concentrations. 
 
5.3.2 Determination of Specificity and Sensitivity for Each Probe 
Once the conditions for the probes were optimized, a blind experiment was 
performed to determine the specificity of each probe. The experiment consisted in 
measuring the fluorescence by qPCR of 10 samples, 5 target and 5 non-target, that were 
organized randomly by another scientist, who knew the order of these samples. With the 
fluorescence results obtained, the samples were assigned as target or non-target compared 
to a positive and negative control, and afterwards the assignment was compared to the 
real identity of the samples.  A sample was assigned as target if the maximum normalized 
fluorescence was higher than a threshold: the mean of the non-target maximum 
normalized fluorescence plus two standard deviations (𝑋)* + 2𝜎)*). This was defined as 
the statistically significant threshold or limit of detection between target and non-target. 
The experiment was performed in triplicate for each probe. For the Clone-13 probe, 9 of 
10 samples were assigned accurately: 4 true positives, 1 false negative, 5 true negatives, 
and 0 false positives (results not shown). For the Armstrong probe, 7 of 10 samples were 
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assigned accurately: 3 true positives, 2 false negatives, 4 true negatives, and 1 false 
positive (results not shown).     
 
5.3.3 Quasi-species Detection 
After the conditions of the qPCR for the probes were optimized and it was shown 
that the probes could detect specifically each strain in samples with mixtures, serum 
samples from mice infected with an unknown strain of LCMV, suspected to be Clone-13, 
were tested to detect Clone-13 or Armstrong strain. Plaque assay was performed with 
these samples and RNA was isolated from plaques from each sample in triplicate. qPCR 
with the Clone-13 probe was performed to test for the presence of this strain in the 
samples. Figure 5.5 shows the normalized fluorescence of the three samples tested 
compared to a positive control (target) and a negative control (non-target). It is observed 
that the maximum fluorescence for the three samples was above the proposed threshold 
in previous experiments (𝑋)* + 2𝜎)*) . Furthermore, a t-student test was performed 
comparing the mean of each sample to the mean of the target or the non-target, resulting 
in a p value of 0.15 or a 15 % probability of having false positives. To compare the 
results with other detection method, the DNA obtained from the samples was sequenced 
and confirmed the results obtained with the tentacle probe for Clone-13 detection. 
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Figure 5.5. Quasi-Species Test of three Serum Samples Obtained from Mice.  
Serum from infected mice with an unknown LCMV strain was tested to detect Clone-13 
with the correspondent probe. The dashed line represents the non-target threshold 
proposed (𝑋)* + 2𝜎)*). 
 
5.3.4 Detection of a Strain in a Mixture of Viruses 
Detection of specific viruses even between the same family is essential, especially 
in clinical samples where samples sometimes present more than one viral infection at a 
time or more than one viral strain. To further test the lower limit of detection of one strain 
in a mixture of the other, mixtures of target and non-target in different proportions were 
tested to detect Clone-13 strain using its specific probe. Figure 5.6 shows the normalized 
maximum fluorescence of the mixtures of Clone13 and Armstrong samples ranging from 
0.1-100 % of Clone-13 DNA. The dashed line represent the limit of detection proposed 
for the blind experiment (𝑋)* + 2𝜎)*). It is observed that the probe can detect to a lower 
limit of detection of approximately 10 % of the Clone-13 when it is present in a mixture 
with Armstrong DNA. 
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Figure 5.6. Determination of the Limit of Detection of the Clone-13 Probe. 
The probe designed to detect Clone-13 is diluted in Armstrong by combining different 
proportions of Clone-13 (target) and Armstrong (non-target) DNA.  
 
5.4 Discussion 
Fast and cost-effective detection methods for viruses are currently needed for 
opportune diagnosis and treatment of viral disease. In this study we tested the specificity 
of Tentacle Probes to detect one strain of LCMV that only differs from the other strain in 
three point mutations, specifically one missense mutation in the region studied (S 
segment). The mutation that was studied causes a change in one amino acid of the 
receptor protein GP1, which also changes the type of infection induced (chronic vs. 
acute) and is the main reason why we chose this mutation above the other two mutations 
present. The design of the probe for the detection of each strain was following the 
calculations proposed by Satterfield et al. In here, the calculated thermodynamic 
parameters (i.e. enthalpy, entropy) with DINAMelt application were used to calculate the 
equilibrium constants and therefore estimate the probe fluorescing when is bound to the 
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target and non-target (Table 5.1). The predicted amount of probe fluorescing for both 
probes did not agree as precisely with what was observed. For the Clone-13 probe, the 
predicted difference in fluorescence between the target and the non-target was 50 % 
higher, while the fluorescence obtained experimentally was ~40 % higher, on average. A 
similar behavior was observed with the probe designed to detect Armstrong strain. This 
can be attributed to the fact that the predicted calculations did not take into account any 
kinetic factors, but only thermodynamic. Kinetic factors, like size of the probe, not only 
can be as important as the thermodynamic ones, but also can define entirely how much 
time a step in the qPCR might need in order to achieve the conformation desired in the 
case of the stem-loop (open or closed) (Gao et al., 2006; Satterfield et al., 2007b).  
Validation of the method was described in detail by optimizing the qPCR 
conditions for each probe, including annealing temperature, MgCl2 concentration and 
starting sample DNA concentration (Figure 5.3 and 5.4).  The annealing temperature was 
expected to be higher than the melting temperature of the individual regions (capture and 
detection) because the principles of cooperativity indicate that the affinities of each part 
of the probe should be slightly weaker than the affinity required to achieve binding of the 
whole probe. However, as mentioned before, calculations did not take into account 
important kinetic factors such as the size of the whole probe and each part in separate 
(Gao et al., 2006) that might have affected the variance in the experimental annealing 
temperature. It is important to mention that the curves observed with the Armstrong 
probe at all temperatures did not show the exponential region usually observed with 
qPCR curves and as it was observed with the Clone-13 probe. This is an indication that 
the Armstrong probe is not as fit as the Clone-13 probe and is in agreement with the 
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thermodynamic predictions of fluorescence with the target and the non-target, where the 
differentiation with the Armstrong probe is not as pronounced as the differentiation 
predicted with the Clone-13 probe (Table 5.1).   
MgCl2 concentration is another important factor because it has a high contribution 
in ionic strength of the reaction and therefore influence directly into the thermodynamics. 
The calculations were performed to use 5 mM of MgCl2 and 1.5 mM for the Clone-13 
and Armstrong probe, respectively. The concentration used for the calculation of the 
Clone-13 probe was the one recommended by Satterfield et al. and the concentration used 
for the calculations of the Armstrong probe was the one recommended by the 
manufacturer to use for an optimal reaction using Platinum Taq polymerase. There was 
an agreement of the expected optimal concentration of MgCl2 with the one observed for 
the Clone-13 probe and Armstrong probe. This shows that the ionic strength used in the 
calculations accurately predicted the optimal salt concentration in the reaction.  
It could be observed that the calculations showed a better differentiation between 
target and non-target for the Clone-13 probe than for the Armstrong probe (Table 5.1). 
The difference between the two concentrations of MgCl2 for the calculations might be 
one of the factors for the lower efficiency of the Armstrong probe compared to the Clone-
13 probe. This difference in efficiency of detecting one strain or the other can also be 
attributed to the thermodynamic advantage of the Clone-13 probe due to the presence of 
the cytosine in the mutation site, instead of the thymine like Armstrong probe. Cytosine 
will hybridize with a guanine forming three hydrogen bonds, meaning the base-pairing 
will be more stable than the hybridization of the mismatch, meaning the anomalous 
cytosine-adenine pairing, favoring the hybrid between the probe and the target (C-G). For 
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the Armstrong probe, the thymine from the probe will hybridize with the adenine forming 
only two hydrogen bonds with the target instead of the hybrid with the non-target 
(mismatch), meaning the anomalous thymine-guanine pairing, which would form three 
hydrogen bonds. Although the probability of the hybridization of with the Armstrong 
probe with the mismatch is low due to the necessary conversion from the keto-thymine to 
the enol-thymine conformation, the hybridization of thymine and adenine (Armstrong 
probe-target) is less favored thermodynamically than the hybridization guanine-cytosine 
(Clone-13 probe-target), in terms of Gibbs free energy.  
Experimentally it was shown that each probe designed could differentiate 
effectively one strain from the other. The blind tests performed with each probe to 
determine the specificity and sensitivity gave a sense of how accurate the probe could 
detect the target strain. The Clone-13 probe showed a better specificity giving results 
with only 10 % of false-negatives. On the other hand, the Armstrong probe showed 
results with 20 % of false-negatives and 10 % of false positives. It was expected that the 
Armstrong probe would have a higher probability of obtaining an inaccurate result, due to 
the smaller difference of expected fluorescence with the target vs. non-target in the initial 
calculations. Nevertheless, these percentages could be lower and further experiments with 
a bigger sample size (>10 samples) could be used to determine the percentage of false-
positives and false-negatives more accurately.  
It is important to highlight that Tentacle Probes can be used as a method to 
monitor the evolution of a virus, specifically its quasispecies and can be more cost-
effective than other methods like hairpin probes (~$16/sample) or deep sequencing 
(~$35/sample).  
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In conclusion, this method reduced false-positives compared to common real time 
PCRs used for other RNA viruses such as Dengue (C.D.C., 2010) with a difference of 
only one point mutation between strains. The reduction of false-positives with this 
method is an advantage when using it with clinical samples overall in tropical regions, 
where many viruses with similar symptoms affect the same population (i.e. Dengue and 
Zika virus) (Guzman et al., 2010; Tsai and Halstead, 2001). Furthermore, detection of 
viral strains in serum using this method was established when we could accurately detect 
Clone-13 virus in the serum samples from infected mice (Figure 5.5).  
Also, the probes could effectively differentiate each strain in virus mixing 
experiments with the two strains. Clone-13 probe can detect down to 10 % of Clone-13 
diluted in Armstrong (Figure 5.6). The detection of one strain in a mix of other strains of 
viruses has a high impact in a detection method because it simulates the conditions of 
many clinical samples. This experiment in particular intended to illustrate two important 
viral phenomena: the presence of quasispecies in the population and even in the same 
host of viral strains and co-infection of two viruses in one host. Infections with RNA 
viruses can often result in the formation of quasispecies of virus strains that can rapidly 
adapt and can develop resistance to anti-viral drugs or vaccines (Domingo et al., 2012). 
Quasispecies of viral strains differ between them in a few mutations, even in only one 
mutation (Domingo et al., 2012; Holmes, 2009; Katzelnick et al., 2015; Lauring and 
Andino, 2010). Accurate detection of one of these quasispecies over another one can be 
crucial to determine possible treatment of the infection, the pathogenicity and the 
evolution of a determined virus in a population. Another scenario where detection of one 
viral strain in a mixed sample is essential is in viral co-infections. Co-infection of two 
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unrelated viruses that affect the same population is very common in the “real world” 
(McAfee et al., 2015). The presence of two or more viruses in a host can modulate the 
immune response and/or alter the disease (Kenney et al., 2015; McAfee et al., 2015). 
Therefore, the use of Tentacle Probes and qPCR for the detection of RNA viruses can be 
widely applied in many situations where high specificity and reduction of false-positives 
is needed.  
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Chapter 6 
6. CONCLUSIONS, RECOMMENDATIONS AND FUTURE WORK 
Viral detection methods need to evolve every day to detect in a timely manner 
emergent or re-emergent viruses. The constant evolution of viruses is an implicit 
challenge for diagnosis and treatment, especially for RNA viruses because of the high 
rate of mutation.  The methods described in this dissertation were proposed to solve some 
of the challenges present in current methods: speed, cost-effectiveness and specificity. 
Monitoring the optical changes of conjugated gold nanoparticles as biosensors is a widely 
studied area, but the proposed method measures changes on the surface of gold 
nanoparticles through static light scattering and an caustic optical device, which detects 
successfully the presence of antibodies in vitro and in serum from infected patients. 
Agreement between this new method and current methods such as dot blot, confirms the 
accuracy and functionality of the method and the device. Nevertheless, as observed with 
the method proposed to detect virus particles, the preparation of the gold nanoparticles is 
crucial to avoid instability and to improve coverage of the gold nanoparticle, increasing 
the chances of detection of the target. To improve the efficacy of conjugated gold 
nanoparticles, an optimization of the preparation of gold nanoparticles was performed, 
leading to the design of a detailed protocol for the preparation of conjugated gold 
nanoparticles that showed successful results. Application of the protocol for preparation 
of homogeneous assay with non-covalent conjugation can benefit broadly the field 
specifically in the preparation of biosensors.  
On the other hand, detection with Tentacle Probes coupled with qPCR gave 
enough specificity to be able to detect one viral strain in a mixture of virus strains. The 
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technique has been previously used with other organisms and the potential application in 
other areas of virology, like detection of quasi-species of a virus or co-infection of related 
viruses, can give a better understanding about viral infections and/or effective treatment 
in a timely manner. Although the design of the Tentacle Probes is based on 
thermodynamic parameters, the technique still needs some improvements at the time of 
predicting more accurately the expected fluorescence and taking into account kinetic 
factors to predict the behavior of the probe better. For future studies with RNA viruses it 
should be studied if the step synthetizing cDNA can be avoided and thus minimize the 
time of the method.  In conclusion, two fast and cost-effective methods were developed 
for the detection of antibodies and virus strains and hopefully this study can give a better 
understanding to the field and contribute to the improvement of diagnostic methods for 
viruses.  
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APPENDIX A 
A. PROTOCOL FOR PREPARATION OF CONJUGATED GOLD NANOPARTICLES 
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PROTOCOL FOR PREPARATION OF CONJUGATED GOLD NANOPARTICLES 
Conjugation: 
An aliquot of 1 ml containing 2.6 x 1010 particles/ml of 60 nm gold colloids (Ted 
Pella Inc, Redding, CA, http://www.tedpella.com) are combined with 10 microliters of 
freshly prepared pH = 5 acetate buffer prior to the addition of 100 microliters of the 
protein concentration necessary for ~90 %, in the case of BSA at least 2 mg/ml.   A 
frozen cold pack should be placed on the tube and the mixture is gently rocked using an 
orbital table for 30 minutes. 
Centrifugation: 
After 30 minutes of incubation, 2.5 µl of a 10 % solution of Tween 20 (Sigma-
Aldrich Corp., St. Louis, MO http://www.sigmaaldrich.com) is added to the mixture, and 
the mixture is rocked again for 5 minutes. Three centrifugation steps are conducted in 
order to reduce the concentration of the unbound protein to gold nanoparticles.  The 
centrifugation conditions used are adapted from Cytodiagnostics Inc. 
(www.cytodiagnostics.com) recommended conditions for each particle size used.  To 
minimize aggregation of gold nanoparticles and ensure re-suspension after centrifugation 
all centrifugation steps should be at 4 ˚C.  
For 60 nm gold colloids, the first centrifugation was for 30 minutes at 1125×g.  
Immediately after centrifugation, as much of the supernatant as possible was carefully 
removed from the pellet.  Once this was accomplished, 1 ml of pH = 5 acetate buffer was 
added to re-suspend the pellet.  2.5 µl of 10% Tween 20 was then added to the suspension 
and the mixture was gently rocked for 5 minutes.  Afterwards, the suspension was 
centrifuged again for 15 minutes at 1125×g.  The same procedure was used following the 
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second centrifugation as the first.  For the 3rd centrifugation, time was shortened to 10 
minutes.  After the third and final centrifugation, the pellet was resuspended in 1 ml PBS 
buffer with azide in preparation for the gold nanoparticle immunoassays. 
When the amount of protein is not enough to cover ~90 % of the surface of the 
gold nanoparticle, a blocking agent can be added to bind the empty spaces on the surface 
not covered by the protein.  For the last resuspension, 500 µl of a solution of blocking 
agent are added and then rocked during 5 min on ice. After rocking, 500 µl of PBS are 
added to the gold nanoparticles. The volume of blocking agent or concentration may vary 
depending on each system. 
Incubation: 
Incubation of the sample with the gold nanoparticle solution shows a similar trend 
at both room temperature and 37 ˚C, although it is highly recommended to incubate at 37 
˚C for 30 min.  
 
